Donghui Li, PhD

Peer-Reviewed Articles

1. Wang Z, Lu Y, Fornage M, Jiao L, Shen J, Li Donghui, Wei P. Identification of novel susceptibility methylation loci for pancreatic cancer in a two-phase epigenome-wide association study. Epigenetics 17(11):1357-1372, 2022. e-Pub 2022. PMID: 35030986.
2. Zheng J, Zhao L, Dong J, Chen H, Li Donghui, Zhang X, Hassan MM, Steck SE, Li X, Xiang YB, Wang H. The role of dietary factors in nonalcoholic fatty liver disease to hepatocellular carcinoma progression: A systematic review. Clin Nutr 41(10):2295-2307, 2022. e-Pub 2022. PMID: 36096063.
3. Wang S, Li M, Lin H, Wang G, Xu Y, Zhao X, Hu C, Zhang Y, Zheng R, Hu R, Shi L, Du R, Su Q, Wang J, Chen Y, Yu X, Yan L, Wang T, Zhao Z, Liu R, Wang X, Li Q, Qin G, Wan Q, Chen G, Xu M, Dai M, Zhang D, Tang X, Gao Z, Shen F, Luo Z, Qin Y, Chen L, Huo Y, Li Q, Ye Z, Zhang Y, Liu C, Wang Y, Wu S, Yang T, Deng H, Zhao J, Lai S, Mu Y, Chen L, Li Donghui, Xu G, Ning G, Wang W, Bi Y, Lu J, 4C Study Group. Amino acids, microbiota-related metabolites, and the risk of incident diabetes among normoglycemic Chinese adults: Findings from the 4C study. Cell Rep Med 3(9):100727, 2022. e-Pub 2022. PMID: 35998626.
4. Zhao R, Ren S, Li C, Guo K, Lu Z, Tian L, He J, Zhang K, Cao Y, Liu S, Li Donghui, Wang Z. Biomarkers for pancreatic cancer based on tissue and serum metabolomics analysis in a multicenter study. Cancer Med. e-Pub 2022. PMID: 36161527.
5. Yuan C, Kim J, Wang QL, Lee AA, Babic A, PanScan/PanC4 I-III Consortium, Amundadottir LT, Klein AP, Li Donghui, McCullough ML, Petersen GM, Risch HA, Stolzenberg-Solomon RZ, Perez K, Ng K, Giovannucci EL, Stampfer MJ, Kraft P, Wolpin BM. The age-dependent association of risk factors with pancreatic cancer. Ann Oncol 33(7):693-701, 2022. e-Pub 2022. PMID: 35398288.
6. Liu Y, Deguchi Y, Wei D, Liu F, Moussalli MJ, Deguchi E, Li Donghui, Wang H, Valentin LA, Colby JK, Wang J, Zheng X, Ying H, Gagea M, Ji B, Shi J, Yao JC, Zuo X, Shureiqi I. Rapid acceleration of KRAS-mutant pancreatic carcinogenesis via remodeling of tumor immune microenvironment by PPARδ. Nat Commun 13(1):2665, 2022. e-Pub 2022. PMID: 35562376.
7. Wang S, Li M, Yan L, He M, Lin H, Xu Y, Wan Q, Qin G, Chen G, Xu M, Wang G, Qin Y, Luo Z, Tang X, Wang T, Zhao Z, Xu Y, Chen Y, Huo Y, Hu R, Ye Z, Dai M, Shi L, Gao Z, Su Q, Mu Y, Zhao J, Chen L, Zeng T, Yu X, Li Q, Shen F, Chen L, Zhang Y, Wang Y, Deng H, Liu C, Wu S, Yang T, Li D, Ning G, Wu T, Wang W, Bi Y, Lu J, 4C Study Group. Metabolomics Study Reveals Systematic Metabolic Dysregulation and Early Detection Markers Associated with Incident Pancreatic Cancer. Int J Cancer 150(7):1091-1100, 2022. e-Pub 2021. PMID: 34792202.
8. Li D, Zheng J, Hatia R, Hassan M, Daniel CR. Dietary Intake of Fatty Acids and Risk of Pancreatic Cancer: A Case-control Study. J Nutr 152(2):439-447, 2022. e-Pub 2021. PMID: 34665254.
9. Yu Y, Chang K, Chen JS, Bohlender RJ, Fowler J, Zhang D, Huang M, Wu X, Schildkraut J, Albright LC, Ye Y, Zhao H, Hildebrandt M, Permuth J, Li D, Scheet P, Huff C. A whole-exome case-control association study to characterize the contribution of rare coding variation to pancreatic cancer risk. HGG Advances 3(1):100078, 2022. e-Pub 2021.
10. Zheng J, Daniel CR, Hatia RI, Stuff J, Abdelhakeem AA, Rashid A, Chun YS, Jalal PK, Kaseb AO, Li D, Hassan MM. Dietary N-Nitroso Compounds and Risk of Hepatocellular Carcinoma: A USA-Based Study. Hepatology 74(6):3161-3173, 2021. e-Pub 2021. PMID: 34233041.
11. Moussa I, Day RS, Li R, Kaseb A, Jalal PK, Daniel-MacDougall C, Hatia RI, Abdelhakeem A, Rashid A, Chun YS, Li D, Hassan MM. Association of dietary fat intake and hepatocellular carcinoma among US adults. Cancer Med 10(20):7308-7319, 2021. e-Pub 2021. PMID: 34535983.
12. Jermusyk A, Zhong J, Connelly KE, Gordon N, Perera S, Abdolalizadeh E, Zhang T, O'Brien A, Hoskins JW, Collins I, Eiser D, Yuan C, PanScan Consortium, PanC4 Consortium, Risch HA, Jacobs EJ, Li D, Du M, Stolzenberg-Solomon RZ, Klein AP, Smith JP, Wolpin BM, Chanock SJ, Shi J, Petersen GM, Westlake CJ, Amundadottir LT. A 584 bp deletion in CTRB2 inhibits chymotrypsin B2 activity and secretion and confers risk of pancreatic cancer. Am J Hum Genet 108(10):1852-1865, 2021. e-Pub 2021. PMID: 34559995.
13. Julián-Serrano S, Yuan F, Wheeler W, Benyamin B, Machiela MJ, Arslan AA, Beane-Freeman LE, Bracci PM, Duell EJ, Du M, Gallinger S, Giles GG, Goodman PJ, Kooperberg C, Marchand LL, Neale RE, Shu XO, Van Den Eeden SK, Visvanathan K, Zheng W, Albanes D, Andreotti G, Ardanaz E, Babic A, Berndt SI, Brais LK, Brennan P, Bueno-de-Mesquita B, Buring JE, Chanock SJ, Childs EJ, Chung CC, Fabiánová E, Foretová L, Fuchs CS, Gaziano JM, Gentiluomo M, Giovannucci EL, Goggins MG, Hackert T, Hartge P, Hassan MM, Holcátová I, Holly EA, Hung RI, Janout V, Kurtz RC, Lee IM, Malats N, McKean D, Milne RL, Newton CC, Oberg AL, Perdomo S, Peters U, Porta M, Rothman N, Schulze MB, Sesso HD, Silverman DT, Thompson IM, Wactawski-Wende J, Weiderpass E, Wenstzensen N, White E, Wilkens LR, Yu H, Zeleniuch-Jacquotte A, Zhong J, Kraft P, Li Donghui, Campbell PT, Petersen GM, Wolpin BM, Risch HA, Amundadottir LT, Klein AP, Yu K, Stolzenberg-Solomon RZ. Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies. Am J Clin Nutr 114(4):1408-1417, 2021. PMID: 34258619.
14. Karlsson Q, Brook MN, Dadaev T, Wakerell S, Saunders EJ, Muir K, Neal DE, Giles GG, MacInnis RJ, Thibodeau SN, McDonnell SK, Cannon-Albright L, Teixeira MR, Paulo P, Cardoso M, Huff C, Li D, Yao Y, Scheet P, Permuth JB, Stanford JL, Dai JY, Ostrander EA, Cussenot O, Cancel-Tassin G, Hoegel J, Herkommer K, Schleutker J, Tammela TLJ, Rathinakannan V, Sipeky C, Wiklund F, Grönberg H, Aly M, Isaacs WB, Dickinson JL, FitzGerald LM, Chua MLK, Nguyen-Dumont T, PRACTICAL Consortium, Schaid DJ, Southey MC, Eeles RA, Kote-Jarai Z. Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study. Eur Urol Oncol 4(4):570-579, 2021. e-Pub 2021. PMID: 33436325.
15. Chen H, Majumdar A, Wang L, Kar S, Brown KM, Feng H, Turman C, Dennis J, Easton D, Michailidou K, Simard J, Breast Cancer Association Consortium (BCAC), Bishop T, Cheng IC, Huyghe JR, Schmit SL, Colorectal Transdisciplinary Study (CORECT), Colon Cancer Family Registry Study (CCFR), Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO), O'Mara TA, Spurdle AB, Endometrial Cancer Association Consortium (ECAC), Gharahkhani P, Schumacher J, Jankowski J, Gocke I, Esophageal Cancer GWAS Consortium, Bondy ML, Houlston RS, Jenkins RB, Melin B, Glioma International Case Control Consortium (GICC), Lesseur C, Ness AR, Diergaarde B, Olshan AF, Head-Neck Cancer GWAS Consortium, Amos CI, Christiani DC, Landi MT, McKay JD, International Lung Cancer Consortium (ILCCO), Brossard M, Iles MM, Law MH, MacGregor S, Melanoma GWAS Consortium, Beesley J, Jones MR, Tyrer J, Winham SJ, Ovarian Cancer Association Consortium (OCAC), Klein AP, Petersen G, Li D, Wolpin BM, Pancreatic Cancer Case-Control Consortium (PANC4), Pancreatic Cancer Cohort Consortium (PanScan), Eeles RA, Haiman CA, Kote-Jarai Z, Schumacher FR, PRACTICAL consortium, CRUK, BPC3, CAPS, PEGASUS, Brennan P, Chanock SJ, Gaborieau V, Purdue MP, Renal Cancer GWAS Consortium, Pharoah P, Hung RJ, Amundadottir LT, Kraft P, Pasaniuc B, Lindström S. Large-scale cross-cancer fine-mapping of the 5p15.33 region reveals multiple independent signals. HGG Adv 2(3), 2021. e-Pub 2021. PMID: 34355204.
16. Morris JS, Hassan MM, Zohner YE, Wang Z, Xiao L, Rashid A, Haque A, Abdel-Wahab R, Mohamed YI, Ballard KL, Wolff RA, George B, Li L, Allen G, Weylandt M, Li D, Wang W, Raghav K, Yao J, Amin HM, Kaseb AO. HepatoScore-14: Measures of Biological Heterogeneity Significantly Improve Prediction of Hepatocellular Carcinoma Risk. Hepatology 73(6):2278-2292, 2021. e-Pub 2021. PMID: 32931023.
17. Mocci E, Kundu P, Wheeler W, Arslan AA, Beane-Freeman LE, Bracci PM, Brennan P, Canzian F, Du M, Gallinger S, Giles GG, Goodman PJ, Kooperberg C, Le Marchand L, Neale RE, Shu XO, Visvanathan K, White E, Zheng W, Albanes D, Andreotti G, Babic A, Bamlet WR, Berndt SI, Blackford AL, Bueno-de-Mesquita B, Buring JE, Campa D, Chanock SJ, Childs EJ, Duell EJ, Fuchs CS, Gaziano JM, Giovannucci EL, Goggins MG, Hartge P, Hassan MM, Holly EA, Hoover RN, Hung RJ, Kurtz RC, Lee IM, Malats N, Milne RL, Ng K, Oberg AL, Panico S, Peters U, Porta M, Rabe KG, Riboli E, Rothman N, Scelo G, Sesso HD, Silverman DT, Stevens VL, Strobel O, Thompson IM, Tjonneland A, Trichopoulou A, Van Den Eeden SK, Wactawski-Wende J, Wentzensen N, Wilkens LR, Yu H, Yuan F, Zeleniuch-Jacquotte A, Amundadottir LT, Li D, Jacobs EJ, Petersen GM, Wolpin BM, Risch HA, Kraft P, Chatterjee N, Klein AP, Stolzenberg-Solomon R. Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3. Cancer Res 81(11):3134-3143, 2021. e-Pub 2021. PMID: 33574088.
18. Moussa I, Day RS, Li R, Du XL, Kaseb AO, Jalal PK, Daniel-MacDougall C, Hatia RI, Abdelhakeem A, Rashid A, Chun YS, Li D, Hassan MM. Dietary Patterns and Hepatocellular Carcinoma Risk among US Adults. Nutrients 13(6), 2021. e-Pub 2021. PMID: 34208122.
19. Song H, Dicks EM, Tyrer J, Intermaggio M, Chenevix-Trench G, Bowtell DD, Traficante N, Group A, Brenton J, Goranova T, Hosking K, Piskorz A, van Oudenhove E, Doherty J, Harris HR, Rossing MA, Duerst M, Dork T, Bogdanova NV, Modugno F, Moysich K, Odunsi K, Ness R, Karlan BY, Lester J, Jensen A, Krüger Kjaer S, Høgdall E, Campbell IG, Lázaro C, Pujara MA, Cunningham J, Vierkant R, Winham SJ, Hildebrandt M, Huff C, Li D, Wu X, Yu Y, Permuth JB, Levine DA, Schildkraut JM, Riggan MJ, Berchuck A, Webb PM, Group OS, Cybulski C, Gronwald J, Jakubowska A, Lubinski J, Alsop J, Harrington P, Chan I, Menon U, Pearce CL, Wu AH, de Fazio A, Kennedy CJ, Goode E, Ramus S, Gayther S, Pharoah P. Population-based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high-grade serous ovarian cancer. J Med Genet 58(5):305-313, 2021. e-Pub 2020. PMID: 32546565.
20. López de Maturana E, Rodríguez JA, Alonso L, Lao O, Molina-Montes E, Martín-Antoniano IA, Gómez-Rubio P, Lawlor R, Carrato A, Hidalgo M, Iglesias M, Molero X, Löhr M, Michalski C, Perea J, O'Rorke M, Barberà VM, Tardón A, Farré A, Muñoz-Bellvís L, Crnogorac-Jurcevic T, Domínguez-Muñoz E, Gress T, Greenhalf W, Sharp L, Arnes L, Cecchini L, Balsells J, Costello E, Ilzarbe L, Kleeff J, Kong B, Márquez M, Mora J, O'Driscoll D, Scarpa A, Ye W, Yu J, PanGenEU Investigators, García-Closas M, Kogevinas M, Rothman N, Silverman DT, SBC/EPICURO Investigators, Albanes D, Arslan AA, Beane-Freeman L, Bracci PM, Brennan P, Bueno-de-Mesquita B, Buring J, Canzian F, Du M, Gallinger S, Gaziano JM, Goodman PJ, Gunter M, LeMarchand L, Li D, Neale RE, Peters U, Petersen GM, Risch HA, Sánchez MJ, Shu XO, Thornquist MD, Visvanathan K, Zheng W, Chanock SJ, Easton D, Wolpin BM, Stolzenberg-Solomon RZ, Klein AP, Amundadottir LT, Marti-Renom MA, Real FX, Malats N. A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer. Genome Med 13(1):15, 2021. e-Pub 2021. PMID: 33517887.
21. Hu C, Lin L, Zhu Y, Zhang Y, Wang S, Zhang J, Qi H, Li M, Zhu Y, Huo Y, Wan Q, Qin Y, Hu R, Shi L, Su Q, Yu X, Yan L, Qin G, Tang X, Chen G, Xu M, Xu Y, Wang T, Zhao Z, Gao Z, Wang G, Shen F, Luo Z, Chen L, Li Q, Ye Z, Zhang Y, Liu C, Wang Y, Yang T, Deng H, Chen L, Zeng T, Li D, Zhao J, Mu Y, Bi Y, Wang W, Ning G, Wu S, Chen Y, Lu J. Association Between Age at Diagnosis of Type 2 Diabetes and Cardiovascular Diseases: A Nationwide, Population-Based, Cohort Study. Front Endocrinol (Lausanne) 12:717069, 2021. e-Pub 2021. PMID: 34671316.
22. Zhong J, Jermusyk A, Wu L, Hoskins JW, Collins I, Mocci E, Zhang M, Song L, Chung CC, Zhang T, Xiao W, Albanes D, Andreotti G, Arslan AA, Babic A, Bamlet WR, Beane-Freeman L, Berndt S, Borgida A, Bracci PM, Brais L, Brennan P, Bueno-de-Mesquita B, Buring J, Canzian F, Childs EJ, Cotterchio M, Du M, Duell EJ, Fuchs C, Gallinger S, Gaziano JM, Giles GG, Giovannucci E, Goggins M, Goodman GE, Goodman PJ, Haiman C, Hartge P, Hasan M, Helzlsouer KJ, Holly EA, Klein EA, Kogevinas M, Kurtz RJ, LeMarchand L, Malats N, Männistö S, Milne R, Neale RE, Ng K, Obazee O, Oberg AL, Orlow I, Patel AV, Peters U, Porta M, Rothman N, Scelo G, Sesso HD, Severi G, Sieri S, Silverman D, Sund M, Tjønneland A, Thornquist MD, Tobias GS, Trichopoulou A, Van Den Eeden SK, Visvanathan K, Wactawski-Wende J, Wentzensen N, White E, Yu H, Yuan C, Zeleniuch-Jacquotte A, Hoover R, Brown K, Kooperberg C, Risch HA, Jacobs EJ, Li D, Yu K, Shu XO, Chanock SJ, Wolpin BM, Stolzenberg-Solomon RZ, Chatterjee N, Klein AP, Smith JP, Kraft P, Shi J, Petersen GM, Zheng W, Amundadottir L. A Transcriptome-Wide Association Study Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer. J Natl Cancer Inst 112(10):1003-1012, 2020. PMID: 31917448.
23. Cristiano S, McKean D, Carey J, Bracci P, Brennan P, Chou M, Du M, Gallinger S, Goggins MG, Hassan MM, Hung RJ, Kurtz RC, Li D, Lu L, Neale R, Olson S, Petersen G, Rabe KG, Fu J, Risch H, Rosner GL, Ruczinski I, Klein AP, Scharpf RB. Bayesian copy number detection and association in large-scale studies. BMC Cancer 20(1):856, 2020. e-Pub 2020.
24. Hu C, Zhang Y, Wang S, Lin L, Peng K, Du R, Qi H, Zhang J, Wang T, Zhao Z, Li M, Xu Y, Xu M, Li D, Bi Y, Wang W, Chen Y, Lu J. Association of bedtime with the risk of non-alcoholic fatty liver disease among middle-aged and elderly Chinese adults with pre-diabetes and diabetes. Diabetes Metab Res Rev 36(6):e3322, 2020. e-Pub 2020. PMID: 32268002.
25. Tang H, Jiang L, Stolzenberg-Solomon RZ, Arslan AA, Beane Freeman LE, Bracci PM, Brennan P, Canzian F, Du M, Gallinger S, Giles GG, Goodman PJ, Kooperberg C, Le Marchand L, Neale RE, Shu XO, Visvanathan K, White E, Zheng W, Albanes D, Andreotti G, Babic A, Bamlet WR, Berndt SI, Blackford A, Bueno-de-Mesquita B, Buring JE, Campa D, Chanock SJ, Childs E, Duell EJ, Fuchs C, Gaziano JM, Goggins M, Hartge P, Hassam MH, Holly EA, Hoover RN, Hung RJ, Kurtz RC, Lee IM, Malats N, Milne RL, Ng K, Oberg AL, Orlow I, Peters U, Porta M, Rabe KG, Rothman N, Scelo G, Sesso HD, Silverman DT, Thompson IM, Tjønneland A, Trichopoulou A, Wactawski-Wende J, Wentzensen N, Wilkens LR, Yu H, Zeleniuch-Jacquotte A, Amundadottir LT, Jacobs EJ, Petersen GM, Wolpin BM, Risch HA, Chatterjee N, Klein AP, Li D, Kraft P, Wei P. Genome-Wide Gene-Diabetes and Gene-Obesity Interaction Scan in 8,255 Cases and 11,900 Controls from PanScan and PanC4 Consortia. Cancer Epidemiol Biomarkers Prev 29(9):1784-1791, 2020. e-Pub 2020. PMID: 32546605.
26. Yuan F, Hung RJ, Walsh N, Zhang H, Platz EA, Wheeler W, Song L, Arslan AA, Beane Freeman LE, Bracci P, Canzian F, Du M, Gallinger S, Giles GG, Goodman PJ, Kooperberg C, Le Marchand L, Neale RE, Rosendahl J, Scelo G, Shu XO, Visvanathan K, White E, Zheng W, Albanes D, Amiano P, Andreotti G, Babic A, Bamlet WR, Berndt SI, Brennan P, Bueno-de-Mesquita B, Buring JE, Campbell PT, Chanock SJ, Fuchs CS, Gaziano JM, Goggins MG, Hackert T, Hartge P, Hassan MM, Holly EA, Hoover RN, Katzke V, Kirsten H, Kurtz RC, Lee IM, Malats N, Milne RL, Murphy N, Ng K, Oberg AL, Porta M, Rabe KG, Real FX, Rothman N, Sesso HD, Silverman DT, Thompson IM, Wactawski-Wende J, Wang X, Wentzensen N, Wilkens LR, Yu H, Zeleniuch-Jacquotte A, Shi J, Duell EJ, Amundadottir LT, Li D, Petersen GM, Wolpin BM, Risch HA, Yu K, Klein AP, Stolzenberg-Solomon R. Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk. Cancer Res 80(18):4004-4013, 2020. e-Pub 2020. PMID: 32641412.
27. Yang T, Tang H, Risch HA, Olson SH, Peterson G, Bracci PM, Gallinger S, Hung RJ, Neale RE, Scelo G, Duell EJ, Kurtz RC, Khaw KT, Severi G, Sund M, Wareham N, Amos CI, Li D, Wei P. Incorporating multiple sets of eQTL weights into gene-by-environment interaction analysis identifies novel susceptibility loci for pancreatic cancer. Genet Epidemiol 44(8):880-892, 2020. e-Pub 2020.
28. Lu J, Li M, Xu Y, Bi Y, Qin Y, Li Q, Wang T, Hu R, Shi L, Su Q, Xu M, Zhao Z, Chen Y, Yu X, Yan L, Du R, Hu C, Qin G, Wan Q, Chen G, Dai M, Zhang D, Gao Z, Wang G, Shen F, Luo Z, Chen L, Huo Y, Ye Z, Tang X, Zhang Y, Liu C, Wang Y, Wu S, Yang T, Deng H, Li D, Lai S, Bloomgarden ZT, Chen L, Zhao J, Mu Y, Ning G, Wang W, 4C Study Group. Early Life Famine Exposure, Ideal Cardiovascular Health Metrics, and Risk of Incident Diabetes: Findings From the 4C Study. Diabetes Care 43(8):1902-1909, 2020. e-Pub 2020. PMID: 32499384.
29. Zhang YD, Hurson AN, Zhang H, Choudhury PP, Easton DF, Milne RL, Simard J, Hall P, Michailidou K, Dennis J, Schmidt MK, Chang-Claude J, Gharahkhani P, Whiteman D, Campbell PT, Hoffmeister M, Jenkins M, Peters U, Hsu L, Gruber SB, Casey G, Schmit SL, O'Mara TA, Spurdle AB, Thompson DJ, Tomlinson I, De Vivo I, Landi MT, Law MH, Iles MM, Demenais F, Kumar R, MacGregor S, Bishop DT, Ward SV, Bondy ML, Houlston R, Wiencke JK, Melin B, Barnholtz-Sloan J, Kinnersley B, Wrensch MR, Amos CI, Hung RJ, Brennan P, McKay J, Caporaso NE, Berndt SI, Birmann BM, Camp NJ, Kraft P, Rothman N, Slager SL, Berchuck A, Pharoah PDP, Sellers TA, Gayther SA, Pearce CL, Goode EL, Schildkraut JM, Moysich KB, Amundadottir LT, Jacobs EJ, Klein AP, Petersen GM, Risch HA, Stolzenberg-Solomon RZ, Wolpin BM, Li D, Eeles RA, Haiman CA, Kote-Jarai Z, Schumacher FR, Al Olama AA, Purdue MP, Scelo G, Dalgaard MD, Greene MH, Grotmol T, Kanetsky PA, McGlynn KA, Nathanson KL, Turnbull C, Wiklund F, Breast Cancer Association Consortium (BCAC), Barrett’s & Esophageal Adenocarcinoma Consortium (BEACON), Colon Cancer Family Registry (CCFR), Transdisciplinary Studies of Genetic Variation in Colorectal Cancer (CORECT), Endometrial Cancer Association Consortium (ECAC), Genetics & Epidemiology of Colorectal Cancer Consortium (GECCO), Melanoma Genetics Consortium (GenoMEL), Glioma International Case-Control Study (GICC), International Lung Cancer Consortium (ILCCO), Integrative Analysis of Lung Cancer Etiology & Risk (INTEGRAL) Consortium, International Consortium of Investigators Working on Non-Hodgkin’s Lymphoma Epidemiologic Studies (InterLymph), Ovarian Cancer Association Consortium (OCAC), Oral Cancer GWAS, Pancreatic Cancer Case-Control Consortium (PanC4), Pancreatic Cancer Cohort Consortium (PanScan), Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome (PRACTICAL), Renal Cancer GWAS, Testicular Cancer Consortium (TECAC), Chanock SJ, Chatterjee N, Garcia-Closas M. Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers. Nat Commun 11(1):3353, 2020. e-Pub 2020. PMID: 32620889.
30. Zhu J, Shu X, Guo X, Liu D, Bao J, Milne RL, Giles GG, Wu C, Du M, White E, Risch HA, Malats N, Duell EJ, Goodman PJ, Li D, Bracci P, Katzke V, Neale RE, Gallinger S, Van Den Eeden SK, Arslan AA, Canzian F, Kooperberg C, Beane Freeman LE, Scelo G, Visvanathan K, Haiman CA, Le Marchand L, Yu H, Petersen GM, Stolzenberg-Solomon R, Klein AP, Cai Q, Long J, Shu XO, Zheng W, Wu L. Associations between Genetically Predicted Blood Protein Biomarkers and Pancreatic Cancer Risk. Cancer Epidemiol Biomarkers Prev 29(7):1501-1508, 2020. e-Pub 2020. PMID: 32439797.
31. Du R, Zheng R, Xu Y, Zhu Y, Yu X, Li M, Tang X, Hu R, Su Q, Wang T, Zhao Z, Xu M, Chen Y, Shi L, Wan Q, Chen G, Dai M, Zhang D, Gao Z, Wang G, Shen F, Luo Z, Qin Y, Chen L, Huo Y, Li Q, Ye Z, Zhang Y, Liu C, Wang Y, Wu S, Yang T, Deng H, Chen L, Zhao J, Mu Y, Li D, Qin G, Wang W, Ning G, Yan L, Bi Y, Lu J, REACTION Study Group ‡. Early-Life Famine Exposure and Risk of Cardiovascular Diseases in Later Life: Findings From the REACTION Study. J Am Heart Assoc 9(7):e014175, 2020. e-Pub 2020. PMID: 32233751.
32. Lu J, Wang S, Li M, Gao Z, Xu Y, Zhao X, Hu C, Zhang Y, Liu R, Hu R, Shi L, Zheng R, Du R, Su Q, Wang J, Chen Y, Yu X, Yan L, Wang T, Zhao Z, Wang X, Li Q, Qin G, Wan Q, Chen G, Xu M, Dai M, Zhang D, Tang X, Wang G, Shen F, Luo Z, Qin Y, Chen L, Huo Y, Li Q, Ye Z, Zhang Y, Liu C, Wang Y, Wu S, Yang T, Deng H, Li D, Lai S, Mu Y, Chen L, Zhao J, Xu G, Ning G, Bi Y, Wang W; 4C Study Group. Association of Serum Bile Acids Profile and Pathway Dysregulation with the Risk of Developing Diabetes among Normoglycemic Chinese. Diabetes Care 44(2):499-510, 2020. PMID: 33355246.
33. Wu X, Du R, Hu C, Cheng D, Ma L, Li M, Xu Y, Xu M, Chen Y, Li D, Bi Y, Wang W, Ning G, Lu J. Resting heart rate is associated with metabolic syndrome and predicted 10-year risk of cardiovascular disease: a cross-sectional study. J Diabetes 11(11):884-894, 2019. e-Pub 2019. PMID: 30941862.
34. Du R, Wu X, Peng K, Lin L, Li M, Xu Y, Xu M, Chen Y, Li D, Lu J, Bi Y, Wang W, Ning G. Serum apolipoprotein B is associated with increased risk of metabolic syndrome among middle-aged and elderly Chinese: A cross-sectional and prospective cohort study. J Diabetes 11(9):752-760, 2019. e-Pub 2019. PMID: 30652427.
35. Wang T, Lu J, Su Q, Chen Y, Bi Y, Mu Y, Chen L, Hu R, Tang X, Yu X, Li M, Xu M, Xu Y, Zhao Z, Yan L, Qin G, Wan Q, Chen G, Dai M, Zhang D, Gao Z, Wang G, Shen F, Luo Z, Qin Y, Chen L, Huo Y, Li Q, Ye Z, Zhang Y, Liu C, Wang Y, Wu S, Yang T, Deng H, Li D, Lai S, Bloomgarden ZT, Shi L, Ning G, Zhao J, Wang W, 4C Study Group. Ideal Cardiovascular Health Metrics and Major Cardiovascular Events in Patients With Prediabetes and Diabetes. JAMA Cardiol 4(9):874-883, 2019. e-Pub 2019. PMID: 31365039.
36. Qiu W, Zhang H, Chen X, Song L, Cui W, Ren S, Wang Y, Guo K, Li D, Chen R, Wang Z. A GPC1-targeted and gemcitabine-loaded biocompatible nanoplatform for pancreatic cancer multimodal imaging and therapy. Nanomedicine (Lond) 14(17):2339-2353, 2019. e-Pub 2019. PMID: 31414945.
37. Li D, Tang H, Wei P, Zheng J, Daniel CR, Hassan MM. Vitamin C and Vitamin E Mitigate the Risk of Pancreatic Ductal Adenocarcinoma from Meat-Derived Mutagen Exposure in Adults in a Case-Control Study. J Nutr 149(8):1443-1450, 2019. PMID: 31100111.
38. Lu J, He J, Li M, Tang X, Hu R, Shi L, Su Q, Peng K, Xu M, Xu Y, Chen Y, Yu X, Yan L, Wang T, Zhao Z, Qin G, Wan Q, Chen G, Dai M, Zhang D, Gao Z, Wang G, Shen F, Luo Z, Qin Y, Chen L, Huo Y, Li Q, Ye Z, Zhang Y, Du R, Cheng D, Liu C, Wang Y, Wu S, Yang T, Deng H, Li D, Lai S, Bloomgarden ZT, Chen L, Zhao J, Mu Y, Ning G, Wang W, Bi Y, 4C Study Group. Predictive Value of Fasting Glucose, Postload Glucose, and Hemoglobin A1c on Risk of Diabetes and Complications in Chinese Adults. Diabetes Care 42(8):1539-1548, 2019. e-Pub 2019. PMID: 31152120.
39. Chen F, Childs EJ, Mocci E, Bracci P, Gallinger S, Li D, Neale RE, Olson SH, Scelo G, Bamlet WR, Blackford AL, Borges M, Brennan P, Chaffee KG, Duggal P, Hassan MJ, Holly EA, Hung RJ, Goggins MG, Kurtz RC, Oberg AL, Orlow I, Yu H, Petersen GM, Risch HA, Klein AP. Analysis of Heritability and Genetic Architecture of Pancreatic Cancer: A PanC4 Study. Cancer Epidemiol Biomarkers Prev 28(7):1238-1245, 2019. e-Pub 2019. PMID: 31015203.
40. Hu C, Mu Y, Wan Q, Qin Y, Hu R, Shi L, Su Q, Yu X, Yan L, Qin G, Tang X, Chen G, Gao Z, Wang G, Shen F, Luo Z, Chen L, Huo Y, Li Q, Ye Z, Zhang Y, Liu C, Wang Y, Wu S, Yang T, Deng H, Chen L, Zhao J, Lu J, Lin L, Li M, Du R, Xu M, Xu Y, Wang T, Zhao Z, Chen Y, Li D, Bi Y, Wang W, Ning G, REACTION Study Group. Association between birth weight and diabetes: Role of body mass index and lifestyle in later life. J Diabetes 12(1):10-20. e-Pub 2019. PMID: 31170331.
41. Julian-Serrano S, Yu K, Yuan F, Wheeler W, Karimi P, Amundadottir L, Jacobs E, Kraft P,Li D , et al. A Pathway Analysis of Hereditary Hemochromatosis-related Genes and Pancreatic Ductal Adenocarcinoma Risk. CURR DEV NUTR 3(Supplement_1), 2019.
42. Zheng J, Stuff J, Tang H, Hassan MM, Daniel CR, Li D. Dietary N-nitroso compounds and risk of pancreatic cancer: results from a large case-control study. Carcinogenesis 40(2):254-262, 2019. e-Pub 2018. PMID: 30475991.
43. Yang T, Chen H, Tang H, Li D, Wei P. A powerful and data-adaptive test for rare-variant-based gene-environment interaction analysis. Stat Med 38(7):1230-1244, 2019. e-Pub 2018. PMID: 30460711.
44. Walsh N, Zhang H, Hyland PL, Yang Q, Mocci E, Zhang M, Childs EJ, Collins I, Wang Z, Arslan AA, Beane-Freeman L, Bracci PM, Brennan P, Canzian F, Duell EJ, Gallinger S, Giles GG, Goggins M, Goodman GE, Goodman PJ, Hung RJ, Kooperberg C, Kurtz RC, Malats N, LeMarchand L, Neale RE, Olson SH, Scelo G, Shu XO, Van Den Eeden SK, Visvanathan K, White E, Zheng W, PanScan and PanC4 consortia, Albanes D, Andreotti G, Babic A, Bamlet WR, Berndt SI, Borgida A, Boutron-Ruault MC, Brais L, Brennan P, Bueno-de-Mesquita B, Buring J, Chaffee KG, Chanock S, Cleary S, Cotterchio M, Foretova L, Fuchs C, M Gaziano JM, Giovannucci E, Goggins M, Hackert T, Haiman C, Hartge P, Hasan M, Helzlsouer KJ, Herman J, Holcatova I, Holly EA, Hoover R, Hung RJ, Janout V, Klein EA, Kurtz RC, Laheru D, Lee IM, Lu L, Malats N, Mannisto S, Milne RL, Oberg AL, Orlow I, Patel AV, Peters U, Porta M, Real FX, Rothman N, Sesso HD, Severi G, Silverman D, Strobel O, Sund M, Thornquist MD, Tobias GS, Wactawski-Wende J, Wareham N, Weiderpass E, Wentzensen N, Wheeler W, Yu H, Zeleniuch-Jacquotte A, Kraft P, Li D, Jacobs EJ, Petersen GM, Wolpin BM, Risch HA, Amundadottir LT, Yu K, Klein AP, Stolzenberg-Solomon RZ. Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer. J Natl Cancer Inst. e-Pub 2018. PMID: 30541042.
45. Pestana RC, Hassan MM, Abdel-Wahab R, Abugabal YI, Girard LM, Li D, Chang P, Raghav K, Morris J, Wolff RA, Rashid A, Amin HM, Kaseb A. Clinical and prognostic significance of circulating levels of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma. Oncotarget 9(102):37721-37732, 2018. e-Pub 2018. PMID: 30701027.
46. McWilliams RR, Wieben ED, Chaffee KG, Antwi SO, Raskin L, Olopade OI, Li D, Highsmith WE, Colon-Otero G, Khanna LG, Permuth JB, Olson JE, Frucht H, Genkinger J, Zheng W, Blot WJ, Wu L, Almada LL, Fernandez-Zapico ME, Sicotte H, Pedersen KS, Petersen GM. CDKN2A Germline Rare Coding Variants and Risk of Pancreatic Cancer in Minority Populations. Cancer Epidemiol Biomarkers Prev 27(11):1364-1370, 2018. e-Pub 2018. PMID: 30038052.
47. Peng K, Chen G, Liu C, Mu Y, Ye Z, Shi L, Zhao J, Chen L, Li Q, Yang T, Yan L, Wan Q, Wu S, Wang G, Luo Z, Tang X, Huo Y, Gao Z, Su Q, Wang Y, Qin G, Deng H, Yu X, Shen F, Chen L, Zhao L, Xu Y, Xu M, Chen Y, Lu J, Lin L, Du R, Dai M, Li M, Wang T, Zhao Z, Zhang D, Bi Y, Li D, Wang W, Ning G, REACTION Study Group. Association between Smoking and Glycemic Control in Diabetic Patients: Results from the REACTION study. J Diabetes 10(5):408-418, 2018. e-Pub 2018. PMID: 29144059.
48. Antwi SO, Bamlet WR, Pedersen KS, Chaffee KG, Risch HA, Shivappa N, Steck SE, Anderson KE, Bracci PM, Polesel J, Serraino D, La Vecchia C, Bosetti C, Li D, Oberg AL, Arslan AA, Albanes D, Duell EJ, Huybrechts I, Amundadottir LT, Hoover R, Mannisto S, Chanock S, Zheng W, Shu XO, Stepien M, Canzian F, Bueno-de-Mesquita B, Quirós JR, Zeleniuch-Jacquotte A, Bruinsma F, Milne RL, Giles GG, Hébert JR, Stolzenberg-Solomon RZ, Petersen GM. Pancreatic Cancer Risk is Modulated by Inflammatory Potential of Diet and ABO Genotype: A Consortia-based Evaluation and Replication Study. Carcinogenesis. e-Pub 2018. PMID: 29800239.
49. Chen X, Zhou H, Li X, Duan N, Hu S, Liu Y, Yue Y, Song L, Zhang Y, Li D, Wang Z. Plectin-1 Targeted Dual-modality Nanoparticles for Pancreatic Cancer Imaging. EBioMedicine 30:129-137, 2018. e-Pub 2018. PMID: 29574092.
50. Wang YN, Lee HH, Chou CK, Yang WH, Wei Y, Chen CT, Yao J, Hsu JL, Zhu C, Ying H, Ye Y, Wang WJ, Lim SO, Xia W, Ko HW, Liu X, Liu CG, Wu X, Wang H, Li D, Prakash LR, Katz MH, Kang Y, Kim M, Fleming JB, Fogelman D, Javle M, Maitra A, Hung MC. Angiogenin/Ribonuclease 5 Is an EGFR Ligand and a Serum Biomarker for Erlotinib Sensitivity in Pancreatic Cancer. Cancer Cell 33(4):752-769.e8, 2018. e-Pub 2018. PMID: 29606349.
51. Jeon CY, Li D, Cleary S, Stolzenberg-Solomon R, Bosetti C, La Vecchia C, Porta M, Toriola AT, Hung RJ, Kurtz RC, Olson SH. The association of recently-diagnosed diabetes and long-term diabetes with survival in pancreatic cancer patients: a pooled analysis. Pancreas, 2018.
52. Du R, Lin L, Cheng D, Xu Y, Xu M, Chen Y, Wang W, Bi Y, Li D, Lu J. Thiazolidinedione therapy and breast cancer risk in diabetic women: A systematic review and meta-analysis. Diabetes Metab Res Rev 34(2), 2018. e-Pub 2017. PMID: 29125710.
53. Klein AP, Wolpin BM, Risch HA, Stolzenberg-Solomon RZ, Mocci E, Zhang M, Canzian F, Childs EJ, Hoskins JW, Jermusyk A, Zhong J, Chen F, Albanes D, Andreotti G, Arslan AA, Babic A, Bamlet WR, Beane-Freeman L, Berndt SI, Blackford A, Borges M, Borgida A, Bracci PM, Brais L, Brennan P, Brenner H, Bueno-de-Mesquita B, Buring J, Campa D, Capurso G, Cavestro GM, Chaffee KG, Chung CC, Cleary S, Cotterchio M, Dijk F, Duell EJ, Foretova L, Fuchs C, Funel N, Gallinger S, M Gaziano JM, Gazouli M, Giles GG, Giovannucci E, Goggins M, Goodman GE, Goodman PJ, Hackert T, Haiman C, Hartge P, Hasan M, Hegyi P, Helzlsouer KJ, Herman J, Holcatova I, Holly EA, Hoover R, Hung RJ, Jacobs EJ, Jamroziak K, Janout V, Kaaks R, Khaw KT, Klein EA, Kogevinas M, Kooperberg C, Kulke MH, Kupcinskas J, Kurtz RJ, Laheru D, Landi S, Lawlor RT, Lee IM, LeMarchand L, Lu L, Malats N, Mambrini A, Mannisto S, Milne RL, Mohelníková-Duchonová B, Neale RE, Neoptolemos JP, Oberg AL, Olson SH, Orlow I, Pasquali C, Patel AV, Peters U, Pezzilli R, Porta M, Real FX, Rothman N, Scelo G, Sesso HD, Severi G, Shu XO, Silverman D, Smith JP, Soucek P, Sund M, Talar-Wojnarowska R, Tavano F, Thornquist MD, Tobias GS, Van Den Eeden SK, Vashist Y, Visvanathan K, Vodicka P, Wactawski-Wende J, Wang Z, Wentzensen N, White E, Yu H, Yu K, Zeleniuch-Jacquotte A, Zheng W, Kraft P, Li D, Chanock S, Obazee O, Petersen GM, Amundadottir LT. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Nat Commun 9(1):556, 2018. e-Pub 2018. PMID: 29422604.
54. Hassan MM, Botrus G, Abdel-Wahab R, Wolff RA, Li D, Tweardy D, Phan AT, Hawk E, Javle M, Lee JS, Torres HA, Rashid A, Lenzi R, Hassabo HM, Abaza Y, Shalaby AS, Lacin S, Morris J, Patt YZ, Amos CI, Khaderi SA, Goss JA, Jalal PK, Kaseb AO. Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma. Clin Gastroenterol Hepatol 15(11):1791-1799, 2017. e-Pub 2017. PMID: 28579181.
55. Li M, Radvanyi L, Yin B, Li J, Chivukula R, Lin K, Lu Y, Shen J, Chang DZ, Li D, Johanning GL, Wang-Johanning F. Downregulation of Human Endogenous Retrovirus Type K (HERV-K) Viral env RNA in Pancreatic Cancer Cells Decreases Cell Proliferation and Tumor Growth. Clin Cancer Res 23(19):5892-5911, 2017. e-Pub 2017. PMID: 28679769.
56. Lin L, Lu J, Chen L, Mu Y, Ye Z, Liu C, Chen G, Shi L, Zhao J, Li Q, Yang T, Yan L, Wan Q, Wu S, Liu Y, Wang G, Luo Z, Tang X, Huo Y, Gao Z, Su Q, Wang Y, Qin G, Deng H, Yu X, Shen F, Chen L, Zhao L, Xu Y, Xu M, Peng K, Du R, Dai M, Li M, Wang T, Zhao Z, Lai S, Li D, Bi Y, Wang W, Ning G, REACTION Study Group. Glycemic status and chronic kidney disease in Chinese adults: Findings from the REACTION study. J Diabetes 9(9):837-845, 2017. e-Pub 2017. PMID: 27734593.
57. Tang H, Wei P, Chang P, Li Y, Yan D, Liu C, Hassan M, Li D. Genetic polymorphisms associated with pancreatic cancer survival: a genome-wide association study. Int J Cancer 141(4):678-686, 2017. e-Pub 2017. PMID: 28470677.
58. Mao Y, Shen J, Lu Y, Lin K, Wang H, Li Y, Chang P, Walker MG, Li D. RNA sequencing analyses reveal novel differentially expressed genes and pathways in pancreatic cancer. Oncotarget 8(26):42537-42547, 2017. PMID: 28418924.
59. Telomeres Mendelian Randomization Collaboration, Haycock PC, Burgess S, Nounu A, Zheng J, Okoli GN, Bowden J, Wade KH, Timpson NJ, Evans DM, Willeit P, Aviv A, Gaunt TR, Hemani G, Mangino M, Ellis HP, Kurian KM, Pooley KA, Eeles RA, Lee JE, Fang S, Chen WV, Law MH, Bowdler LM, Iles MM, Yang Q, Worrall BB, Markus HS, Hung RJ, Amos CI, Spurdle AB, Thompson DJ, O'Mara TA, Wolpin B, Amundadottir L, Stolzenberg-Solomon R, Trichopoulou A, Onland-Moret NC, Lund E, Duell EJ, Canzian F, Severi G, Overvad K, Gunter MJ, Tumino R, Svenson U, van Rij A, Baas AF, Bown MJ, Samani NJ, van t'Hof FNG, Tromp G, Jones GT, Kuivaniemi H, Elmore JR, Johansson M, Mckay J, Scelo G, CarrerasTorres R, Gaborieau V, Brennan P, Bracci PM, Neale RE, Olson SH, Gallinger S,Li D, Petersen GM,Risch HA, Klein AP, Han J, Abnet CC, Freedman ND, Taylor PR, Maris JM, Aben KK, Kiemeney LA, Vermeulen SH, Wiencke JK, Walsh KM, Wrensch M, Rice T, Turnbull C, Litchfield K, Paternoster L, Standl M, Abecasis GR, SanGiovanni JP, Li Y, Mijatovic V, Sapkota Y, Low SK, Zondervan KT, Montgomery GW, Nyholt DR, van Heel DA, Hunt K, Arking DE, Ashar FN, Sotoodehnia N, Woo D, Rosand J, Comeau ME, Brown WM, Silverman EK, Hokanson JE, Cho MH, Hui J, Ferreira MA, Thompson PJ, Morrison AC, Felix JF, Smith NL, Christiano AM, Petukhova L, Betz RC, Fan X, Zhang X, Zhu C, Langefeld CD, Thompson SD, Wang F, Lin X, Schwartz DA, Fingerlin T, Rotter JI, Cotch MF, Jensen RA, Munz M, Dommisch H, Schaefer AS, Han F, Ollila HM, Hillary RP, Albagha O, Ralston SH, Zeng C, Zheng W, Shu XO, Reis A, Uebe S, Hüffmeier U, Kawamura Y, Otowa T, Sasaki T, Hibberd ML, Davila S, Xie G, Siminovitch K, Bei JX, Zeng YX, Försti A, Chen B, Landi S, Franke A, Fischer A, Ellinghaus D, Flores C, Noth I, Ma SF, Foo JN, Liu J, Kim JW, Cox DG, Delattre O, Mirabeau O, Skibola CF, Tang CS, Garcia-Barcelo M, Chang KP, Su WH, Chang YS, Martin NG, Gordon S, Wade TD, Lee C, Kubo M, Cha PC, Nakamura Y, Levy D, Kimura M, Hwang SJ, Hunt S, Spector T,Soranzo N,Man. Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study. JAMA Oncol 3(5):636-651, 2017. PMID: 28241208.
60. Andersen DK, Korc M, Petersen GM, Eibl G, Li D, Rickels MR, Chari ST, Abbruzzese JL. Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer. Diabetes 66(5):1103-1110, 2017. PMID: 28507210.
61. Chen C-T, Chen Y-C, Du Y, Han Z, Ying H, Bouchard R, Hsu JL, Hsu J-M, Mitcham T, Chen MK, Sun H-L Sun, Chang SS, Li D, Chang P, DePinho RA, and Hung M-C. Tumor vessel-targeting fusion protein elicits chemotherapeutic bystander effect in pancreatic ductal adenocarcinoma. Am J Can Res 7(3):657-72, 2017.
62. Pelucchi C, Rosato V, Bracci PM, Li D, Neale RE, Lucenteforte E, Serraino D, Anderson KE, Fontham E, Holly EA, Hassan MM, Polesel J, Bosetti C, Strayer L, Su J, Boffetta P, Duell EJ, La Vecchia C. Dietary acrylamide and the risk of pancreatic cancer in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol 28(2):408-414, 2017. PMID: 27836886.
63. Du R, Sun W, Lin L, Sun J, Peng K, Xu Y, Xu M, Chen Y, Bi Y, Wang W, Li D, Lu J. Serum CA 19-9 and Risk of Incident Diabetes In Middle-aged and Elderly Chinese: A Prospective Cohort Study. Acta Diabetologica 54(2):201-8, 2017. e-Pub 2016. PMID: 27804035.
64. Luo Z, Li Y, Zuo M, Liu C, Yan D, Wang H, Li D. Effect of NR5A2 inhibition on pancreatic cancer stem cell (CSC) properties and epithelial-mesenchymal transition (EMT) markers. Mol Carcinog 56(5):1438-48, 2017. e-Pub 2016. PMID: 27996162.
65. Allenson K, Castillo J, San Lucas FA, Scelo G, Kim DU, Bernard V, Davis G, Kumar T, Katz M, Overman MJ, Foretova L, Fabianova E, Holcatova I, Janout V, Meric-Bernstam F, Gascoyne P, Wistuba I, Varadhachary G, Brennan P, Hanash S, Li D, Maitra A Alvarez H. High Prevalence of Mutant KRAS in Circulating Exosome-derived DNA from Early Stage Pancreatic Cancer Patients. Ann Oncol 28(4):741-7, 2017. e-Pub 2017. PMID: 28104621.
66. Shi J, Park JH, Duan J, Berndt ST, Moy W, Yu K, Song L, Wheeler W, Hua X, Silverman D, Garcia-Closas M, Hsiung CA, Figueroa JD, Cortessis VK, Malats N, Karagas MR, Vineis P, Chang IS, Lin D, Zhou B, Seow A, Matsuo K, Hong YC, Caporaso NE, Wolpin B, Jacobs E, Petersen GM, Klein AP, Li D, Risch H, Sanders AR, Hsu L, Schoen RE, Brenner H, MGS (Molecular Genetics of Schizophrenia) GWAS Consortium, GECCO (The Genetics and Epidemiology of Colorectal Cancer Consortium), GAME-ON/TRICL (Transdisciplinary Research in Cancer of the Lung) GWAS Consortium, PRACTICAL (PRostate cancer AssoCiation group To Investigate Cancer Associated aLterations) Consortium, PanScan Consortium, GAME-ON/ELLIPSE Consortium, Stolzenberg-Solomon R, Gejman P, Lan Q, Rothman N, Amundadottir LT, Landi MT, Levinson DF, Chanock SJ, Chatterjee N. Winner's Curse Correction and Variable Thresholding Improve Performance of Polygenic Risk Modeling Based on Genome-Wide Association Study Summary-Level Data. PLoS Genet 12(12):e1006493, 2016. e-Pub 2016. PMID: 28036406.
67. Liu C, Eng C, Shen J, Lu Y, Takata Y, Mehdizadeh A, Chang GJ, Rodriguez-Bigas MA, Li Y, Chang P, Mao Y, Hassan MM, Wang F, Li D. Serum exosomal miR-4772-3p is a predictor of tumor recurrence in stage II and III colon cancer. Oncotarget 7(46):76250-76260, 2016. e-Pub 2016. PMID: 27788488.
68. Sun W, Lu J, Wu S, Bi Y, Wang W, Mu Y, Zha J, Liu C, Chen L, Shi L, Li Q, Yang T, Yan L, Wan Q, Liu Y, Wang G, Luo Z, Tang X, Chen G, Huo Y, Gao Z, Su Q, Ye Z, Wang Y, Qin G, Deng H, Yu X, Shen F, Chen L, Zhao L, Wang T, Sun J, Xu M, Xu Y, Chen Y, Dai M, Zhang J, Zhang D, Lai S, Li D, Ning G. Association of insulin resistance with breast, ovarian, endometrial and cervical cancers in non-diabetic women. Am J Can Res 6(10):2334-44, 2016.
69. Zhang M, Wang Z, Obazee O, Jia J, Childs EJ, Hoskins J, Figlioli G, Mocci E, Collins I, Chung CC, Hautman C, Arslan AA, Beane-Freeman L, Bracci PM, Buring J, Duell EJ, Gallinger S, Giles GG, Goodman GE, Goodman PJ, Kamineni A, Kolonel LN, Kulke MH, Malats N, Olson SH, Sesso HD, Visvanathan K, White E, Zheng W, Abnet CC, Albanes D, Andreotti G, Brais L, Bueno-de-Mesquita HB, Basso D, Berndt SI, Boutron-Ruault MC, Bijlsma MF, Brenner H, Burdette L, Campa D, Caporaso NE, Capurso G, Cavestro GM, Cotterchio M, Costello E, Elena J, Boggi U, Gaziano JM, Gazouli M, Giovannucci EL, Goggins M, Gross M, Haiman CA, Hassan M, Helzlsouer KJ, Hu N, Hunter DJ, Iskierka-Jazdzewska E, Jenab M, Kaaks R, Key TJ, Khaw KT, Klein EA, Kogevinas M, Krogh V, Kupcinskas J, Kurtz RC, Landi MT, Landi S, Le Marchand L, Mambrini A, Mannisto S, Milne RL, Neale RE, Oberg AL, Panico S, Patel AV, Peeters PH, Peters U, Pezzilli R, Porta M, Purdue M, Quiros JR, Riboli E, Rothman N, Scarpa A, Scelo G, Shu XO, Silverman DT, Soucek P, Strobel O, Sund M, Malecka-Panas E, Taylor PR, Tavano F, Travis RC, Thornquist M, Tjønneland A, Tobias GS, Trichopoulos D, Vashist Y, Vodicka P, Wactawski-Wende J, Wentzensen N, Yu H, Yu K, Zeleniuch-Jacquotte A, Kooperberg C, Risch HA, Jacobs EJ, Li D, Fuchs C, Hoover R, Hartge P, Chanock SJ, Petersen GM, Stolzenberg-Solomon RS, Wolpin BM, Kraft P, Klein AP, Canzian F, Amundadottir LT. Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21. Oncotarget 7(41):66328-66343, 2016. e-Pub 2016. PMID: 27579533.
70. Wang Z, Tong M, Chen X, Hu S, Yang Z, Zhang Y, Zhou H, Wu Y, Li X, Li D. Survivin-targeted nanoparticles for pancreatic tumor imaging in mouse model. Nanomedicine 12(6):1651-61, 2016. e-Pub 2016. PMID: 26995092.
71. Abaza Y, Abdel-Wahab R, Li D, Kaseb AO, Wolff RA, Raghav K, Shalaby AS, Sahin IH, Morris J, Hawk E, Phan AT, Hassan MM. Association between the job types and the risk of hepatocellular carcinoma in the United States. J Epi Res 3(1), 2016. e-Pub 2016.
72. Lu J, Mu Y, Su Q, Shi L, Liu C, Zhao J, Chen L, Li Q, Yang T, Yan L, Wan Q, Wu S, Liu Y, Wang G, Luo Z, Tang X, Chen G, Huo Y, Gao Z, Ye Z, Wang Y, Qin G, Deng H, Yu X, Shen F, Chen L, Zhao L, Sun J, Sun W, Wang T, Du R, Lin L, Dai M, Xu Y, Xu M, Bi Y, Lai S, Li D, Wang W, Ning G, REACTION Study Group. Reduced Kidney Function Is Associated With Cardiometabolic Risk Factors, Prevalent and Predicted Risk of Cardiovascular Disease in Chinese Adults: Results From the REACTION Study. J Am Heart Assoc 5(7), 2016. e-Pub 2016. PMID: 27451464.
73. Zuo M, Rashid A, Wang Y, Jain A, Li D, Behari A, Kapoor VK, Koay EJ, Chang P, Vauthey JN, Li Y, Espinoza JA, Roa JC, Javle M. RNA sequencing-based analysis of gallbladder cancer reveals the importance of the liver X receptor and lipid metabolism in gallbladder cancer. Oncotarget 7(23):35302-12, 2016. PMID: 27167107.
74. Machiela MJ, Zhou W, Karlins E, Sampson JN, Freedman ND, Yang Q, Hicks B, Dagnall C, Hautman C, Jacobs KB, Abnet CC, Aldrich MC, Amos C, Amundadottir LT, Arslan AA, Beane-Freeman LE, Berndt SI, Black A, Blot WJ, Bock CH, Bracci PM, Brinton LA, Bueno-de-Mesquita HB, Burdett L, Buring JE, Butler MA, Canzian F, Carreón T, Chaffee KG, Chang IS, Chatterjee N, Chen C, Chen C, Chen K, Chung CC, Cook LS, Crous Bou M, Cullen M, Davis FG, De Vivo I, Ding T, Doherty J, Duell EJ, Epstein CG, Fan JH, Figueroa JD, Fraumeni JF, Friedenreich CM, Fuchs CS, Gallinger S, Gao YT, Gapstur SM, Garcia-Closas M, Gaudet MM, Gaziano JM, Giles GG, Gillanders EM, Giovannucci EL, Goldin L, Goldstein AM, Haiman CA, Hallmans G, Hankinson SE, Harris CC, Henriksson R, Holly EA, Hong YC, Hoover RN, Hsiung CA, Hu N, Hu W, Hunter DJ, Hutchinson A, Jenab M, Johansen C, Khaw KT, Kim HN, Kim YH, Kim YT, Klein AP, Klein R, Koh WP, Kolonel LN, Kooperberg C, Kraft P, Krogh V, Kurtz RC, LaCroix A, Lan Q, Landi MT, Marchand LL, Li D, Liang X, Liao LM, Lin D, Liu J, Lissowska J, Lu L, Magliocco AM, Malats N, Matsuo K, McNeill LH, McWilliams RR, Melin BS, Mirabello L, Moore L, Olson SH, Orlow I, Park JY, Patiño-Garcia A, Peplonska B, Peters U, Petersen GM, Pooler L, Prescott J, Prokunina-Olsson L, Purdue MP, Qiao YL, Rajaraman P, Real FX, Riboli E, Risch HA, Rodriguez-Santiago B, Ruder AM, Savage SA, Schumacher F, Schwartz AG, Schwartz KL, Seow A, Wendy Setiawan V, Severi G, Shen H, Sheng X, Shin MH, Shu XO, Silverman DT, Spitz MR, Stevens VL, Stolzenberg-Solomon R, Stram D, Tang ZZ, Taylor PR, Teras LR, Tobias GS, Van Den Berg D, Visvanathan K, Wacholder S, Wang JC, Wang Z, Wentzensen N, Wheeler W, White E, Wiencke JK, Wolpin BM, Wong MP, Wu C, Wu T, Wu X, Wu YL, Wunder JS, Xia L, Yang HP, Yang PC, Yu K, Zanetti KA, Zeleniuch-Jacquotte A, Zheng W, Zhou B, Ziegler RG, Perez-Jurado LA, Caporaso NE, Rothman N, Tucker M, Dean MC, Yeager M, Chanock SJ. Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome. Nat Commun 7:11843, 2016. e-Pub 2016. PMID: 27291797.
75. Shinozuka K, Tang H, Jones RB, Li D, Nieto Y. Impact of Polymorphic Variations of Gemcitabine Metabolism, DNA Damage Repair, and Drug-Resistance Genes on the Effect of High-Dose Chemotherapy for Relapsed or Refractory Lymphoid Malignancies. Biol Blood Marrow Transplant 22(5):843-9, 2016. e-Pub 2015. PMID: 26743341.
76. San Lucas FA, Allenson K, Bernard V, Castillo J, Kim DU, Ellis K, Ehli EA, Davies GE, Petersen JL, Li D, Wolff R, Katz M, Varadhachary G, Wistuba I, Maitra A, Alvarez H. Minimally invasive genomic and transcriptomic profiling of visceral cancers by next-generation sequencing of circulating exosomes. Ann Oncol 27(4):635-41, 2016. e-Pub 2015. PMID: 26681674.
77. Li D, Moughan J, Crane C, Hoffman JP, Regine WF, Abrams RA, Safran H, Liu C, Chang P, Freedman GM, Winter KA, Guha C, Abbruzzese JL. RECQ1 A159C Polymorphism Is Associated With Overall Survival of Patients With Resected Pancreatic Cancer: A Replication Study in NRG Oncology Radiation Therapy Oncology Group 9704. Int J Radiat Oncol Biol Phys 94(3):554-60, 2016. e-Pub 2015. PMID: 26725729.
78. Sun W, Shi L, Ye Z, Mu Y, Liu C, Zhao J, Chen L, Li Q, Yang T, Yan L, Wan Q, Wu S, Liu Y, Wang G, Luo Z, Tang X, Chen G, Huo Y, Gao Z, Su Q, Wang Y, Qin G, Deng H, Yu X, Shen F, Chen L, Zhao L, Sun J, Ding L, Xu Y, Xu M, Dai M, Wang T, Zhang D, Lu J, Bi Y, Lai S, Li D, Wang W, Ning G, REACTION Study Group. Association between the change in body mass index from early adulthood to midlife and subsequent type 2 diabetes mellitus. Obesity (Silver Spring) 24(3):703-9, 2016. e-Pub 2016. PMID: 26833544.
79. Lu J, Chen Y, Bi Y, Wang T, Zhang J, Li M, Xu M, Xu Y, Li D, Wang W, and Ning G. Age at Menarche is Associated with Non-alcoholic Fatty Liver Disease in Postmenopausal Chinese Women. J Diabetes 9(1):53-60, 2016. PMID: 26800495.
80. McWilliams RR, Maisonneuve P, Bamlet WR, Petersen GM, Li D, Risch HA, Yu H, Fontham ET, Luckett B, Bosetti C, Negri E, La Vecchia C, Talamini R, Bueno de Mesquita HB, Bracci P, Gallinger S, Neale RE, Lowenfels AB. Risk Factors for Early-Onset and Very-Early-Onset Pancreatic Adenocarcinoma: A Pancreatic Cancer Case-Control Consortium (PanC4) Analysis. Pancreas 45(2):311-6, 2016. PMID: 26646264.
81. Lujan-Barroso L, Zhang W, Gao Y-T, Yu H, Bracci PM, Baghurst PA, Bueno-de-Mesquita HB, Gallinger S, Holcatova I, Ji B-T, La Vecchia MD, Lagio P, Li D, Miller AB, Olson S, Scélo G, Serraino D, Zatonski W, Risch HA, Duell EJ. Menstrual and reproductive factors, exogenous hormone use and risk of pancreatic cancer: analysis from the international pancreatic cancer case-control consortium (PanC4). Pancreas 45(10):1401-10, 2016.
82. Sampson JN, Wheeler WA, Yeager M, Panagiotou O, Wang Z, Berndt SI, Lan Q, Abnet CC, Amundadottir LT, Figueroa JD, Landi MT, Mirabello L, Savage SA, Taylor PR, Vivo ID, McGlynn KA, Purdue MP, Rajaraman P, Adami HO, Ahlbom A, Albanes D, Amary MF, An SJ, Andersson U, Andriole G, Andrulis IL, Angelucci E, Ansell SM, Arici C, Armstrong BK, Arslan AA, Austin MA, Baris D, Barkauskas DA, Bassig BA, Becker N, Benavente Y, Benhamou S, Berg C, Van Den Berg D, Bernstein L, Bertrand KA, Birmann BM, Black A, Boeing H, Boffetta P, Boutron-Ruault MC, Bracci PM, Brinton L, Brooks-Wilson AR, Bueno-de-Mesquita HB, Burdett L, Buring J, Butler MA, Cai Q, Cancel-Tassin G, Canzian F, Carrato A, Carreon T, Carta A, Chan JK, Chang ET, Chang GC, Chang IS, Chang J, Chang-Claude J, Chen CJ, Chen CY, Chen C, Chen CH, Chen C, Chen H, Chen K, Chen KY, Chen KC, Chen Y, Chen YH, Chen YS, Chen YM, Chien LH, Chirlaque MD, Choi JE, Choi YY, Chow WH, Chung CC, Clavel J, Clavel-Chapelon F, Cocco P, Colt JS, Comperat E, Conde L, Connors JM, Conti D, Cortessis VK, Cotterchio M, Cozen W, Crouch S, Crous-Bou M, Cussenot O, Davis FG, Ding T, Diver WR, Dorronsoro M, Dossus L, Duell EJ, Ennas MG, Erickson RL, Feychting M, Flanagan AM, Foretova L, Fraumeni JF, Freedman ND, Beane Freeman LE, Fuchs C, Gago-Dominguez M, Gallinger S, Gao YT, Gapstur SM, Garcia-Closas M, García-Closas R, Gascoyne RD, Gastier-Foster J, Gaudet MM, Gaziano JM, Giffen C, Giles GG, Giovannucci E, Glimelius B, Goggins M, Gokgoz N, Goldstein AM, Gorlick R, Gross M, Grubb R, Gu J, Guan P, Gunter M, Guo H, Habermann TM, Haiman CA, Halai D, Hallmans G, Hassan M, Hattinger C, He Q, He X, Helzlsouer K, Henderson B, Henriksson R, Hjalgrim H, Hoffman-Bolton J, Hohensee C, Holford TR, Holly EA, Hong YC, Hoover RN, Horn-Ross PL, Hosain GM, Hosgood HD, Hsiao CF, Hu N, Hu W, Hu Z, Huang MS, Huerta JM, Hung JY, Hutchinson A, Inskip PD, Jackson RD, Jacobs EJ, Jenab M, Jeon HS, Ji BT, Jin G, Jin L, Johansen C, Johnson A, Jung YJ, Kaaks R, Kamineni A, Ka. Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types. J Natl Cancer Inst 107(12), 2015. e-Pub 2015. PMID: 26464424.
83. Campa D, Rizzato C, Stolzenberg-Solomon R, Pacetti P, Vodicka P, Cleary SP, Capurso G, Bueno-de-Mesquita HB, Werner J, Gazouli M, Butterbach K, Ivanauskas A, Giese N, Petersen GM, Fogar P, Wang Z, Bassi C, Ryska M, Theodoropoulos GE, Kooperberg C, Li D, Greenhalf W, Pasquali C, Hackert T, Fuchs CS, Mohelnikova-Duchonova B, Sperti C, Funel N, Dieffenbach AK, Wareham NJ, Buring J, Holcátová I, Costello E, Zambon CF, Kupcinskas J, Risch HA, Kraft P, Bracci PM, Pezzilli R, Olson SH, Sesso HD, Hartge P, Strobel O, Malecka-Panas E, Visvanathan K, Arslan AA, Pedrazzoli S, Soucek P, Gioffreda D, Key TJ, Talar-Wojnarowska R, Scarpa A, Mambrini A, Jacobs EJ, Jamroziak K, Klein A, Tavano F, Bambi F, Landi S, Austin MA, Vodickova L, Brenner H, Chanock SJ, Delle Fave G, Piepoli A, Cantore M, Zheng W, Wolpin BM, Amundadottir LT, Canzian F. The TERT gene harbors multiple variants associated with pancreatic cancer susceptibility. Int J Cancer 137(9):2175-83, 2015. e-Pub 2015. PMID: 25940397.
84. Hassan MM, Abdel-Wahab R, Li D, Kaseb AO. Reply. Gastroenterology 149(6):1643-4, 2015. e-Pub 2015. PMID: 26433110.
85. Mao Y, Tao M, Jia X, Xu H, Chen K, Tang H, Li D. Effect of Diabetes Mellitus on Survival in Patients with Pancreatic Cancer: A Systematic Review and Meta-analysis. Sci Rep 5:17102, 2015. e-Pub 2015. PMID: 26598798.
86. Childs EJ, Mocci E, Campa D, Bracci PM, Gallinger S, Goggins M, Li D, Neale RE, Olson SH, Scelo G, Amundadottir LT, Bamlet WR, Bijlsma MF, Blackford A, Borges M, Brennan P, Brenner H, Bueno-de-Mesquita HB, Canzian F, Capurso G, Cavestro GM, Chaffee KG, Chanock SJ, Cleary SP, Cotterchio M, Foretova L, Fuchs C, Funel N, Gazouli M, Hassan M, Herman JM, Holcatova I, Holly EA, Hoover RN, Hung RJ, Janout V, Key TJ, Kupcinskas J, Kurtz RC, Landi S, Lu L, Malecka-Panas E, Mambrini A, Mohelnikova-Duchonova B, Neoptolemos JP, Oberg AL, Orlow I, Pasquali C, Pezzilli R, Rizzato C, Saldia A, Scarpa A, Stolzenberg-Solomon RZ, Strobel O, Tavano F, Vashist YK, Vodicka P, Wolpin BM, Yu H, Petersen GM, Risch HA, Klein AP. Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. Nat Genet 47(8):911-6, 2015. e-Pub 2015. PMID: 26098869.
87. Li D, Pise MN, Overman MJ, Liu C, Tang H, Vadhan-Raj S, Abbruzzese JL. ABO non-O type as a risk factor for thrombosis in patients with pancreatic cancer. Cancer Med. e-Pub 2015. PMID: 26275671.
88. Wang T, Lu J, Wang W, Mu Y, Zhao J, Liu C, Chen L, Shi L, Li Q, Yang T, Yan L, Wan Q, Wu S, Liu Y, Wang G, Luo Z, Tang X, Chen G, Huo Y, Gao Z, Su Q, Ye Z, Wang Y, Qin G, Deng H, Yu X, Shen F, Chen L, Zhao L, Xu M, Sun J, Bi Y, Lai S, Bloomgarden ZT, Li D, Ning G. Sleep duration and snoring associate with hypertension and glycaemic control in patients with diabetes. Diabet Med 32(8):1001-7, 2015. e-Pub 2015. PMID: 25996982.
89. Hassan MM, Abdel-Wahab R, Kaseb A, Shalaby A, Phan AT, El-Serag HB, Hawk E, Morris J, Singh Raghav KP, Lee JS, Vauthey JN, Bortus G, Torres HA, Amos CI, Wolff RA, Li D. Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma. Gastroenterology 149(1):119-29, 2015. e-Pub 2015. PMID: 25836985.
90. Zhen DB, Rabe KG, Gallinger S, Syngal S, Schwartz AG, Goggins MG, Hruban RH, Cote ML, McWilliams RR, Roberts NJ, Cannon-Albright LA, Li D, Moyes K, Wenstrup RJ, Hartman AR, Seminara D, Klein AP, Petersen GM. BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study. Genet Med 17(7):569-577, 2015. e-Pub 2014. PMID: 25356972.
91. Suzuki H, Roa JC, Kawamoto T, Ishige K, Wistuba II, Li D, Thomas MB, Shoda J. Expression of insulin-like growth factor I receptor as a biomarker for predicting prognosis in biliary tract cancer patients. Mol Clin Oncol 3(3):464-470, 2015. e-Pub 2015. PMID: 26137252.
92. Machiela MJ, Zhou W, Sampson JN, Dean MC, Jacobs KB, Black A, Brinton LA, Chang IS, Chen C, Chen C, Chen K, Cook LS, Crous Bou M, De Vivo I, Doherty J, Friedenreich CM, Gaudet MM, Haiman CA, Hankinson SE, Hartge P, Henderson BE, Hong YC, Hosgood HD, Hsiung CA, Hu W, Hunter DJ, Jessop L, Kim HN, Kim YH, Kim YT, Klein R, Kraft P, Lan Q, Lin D, Liu J, Le Marchand L, Liang X, Lissowska J, Lu L, Magliocco AM, Matsuo K, Olson SH, Orlow I, Park JY, Pooler L, Prescott J, Rastogi R, Risch HA, Schumacher F, Seow A, Setiawan VW, Shen H, Sheng X, Shin MH, Shu XO, VanDen Berg D, Wang JC, Wentzensen N, Wong MP, Wu C, Wu T, Wu YL, Xia L, Yang HP, Yang PC, Zheng W, Zhou B, Abnet CC, Albanes D, Aldrich MC, Amos C, Amundadottir LT, Berndt SI, Blot WJ, Bock CH, Bracci PM, Burdett L, Buring JE, Butler MA, Carreón T, Chatterjee N, Chung CC, Cook MB, Cullen M, Davis FG, Ding T, Duell EJ, Epstein CG, Fan JH, Figueroa JD, Fraumeni JF, Freedman ND, Fuchs CS, Gao YT, Gapstur SM, Patiño-Garcia A, Garcia-Closas M, Gaziano JM, Giles GG, Gillanders EM, Giovannucci EL, Goldin L, Goldstein AM, Greene MH, Hallmans G, Harris CC, Henriksson R, Holly EA, Hoover RN, Hu N, Hutchinson A, Jenab M, Johansen C, Khaw KT, Koh WP, Kolonel LN, Kooperberg C, Krogh V, Kurtz RC, LaCroix A, Landgren A, Landi MT, Li D, Liao LM, Malats N, McGlynn KA, McNeill LH, McWilliams RR, Melin BS, Mirabello L, Peplonska B, Peters U, Petersen GM, Prokunina-Olsson L, Purdue M, Qiao YL, Rabe KG, Rajaraman P, Real FX, Riboli E, Rodríguez-Santiago B, Rothman N, Ruder AM, Savage SA, Schwartz AG, Schwartz KL, Sesso HD, Severi G, Silverman DT, Spitz MR, Stevens VL, Stolzenberg-Solomon R, Stram D, Tang ZZ, Taylor PR, Teras LR, Tobias GS, Viswanathan K, Wacholder S, Wang Z, Weinstein SJ, Wheeler W, White E, Wiencke JK, Wolpin BM, Wu X, Wunder JS, Yu K, Zanetti KA, Zeleniuch-Jacquotte A, Ziegler RG, de Andrade M, Barnes KC, Beaty TH, Bierut LJ, Desch KC, Doheny KF, Feenstra B, Ginsburg D, Heit JA, Kang JH, Laurie CA, Li JZ, Lowe WL, Maraz. Characterization of large structural genetic mosaicism in human autosomes. Am J Hum Genet 96(3):487-97, 2015. PMID: 25748358.
93. Sun JC, Xu M, Lu JL, Bi YF, Mu YM, Zhao JJ, Liu C, Chen LL, Shi LX, Li Q, Yang T, Yan L, Wan Q, Wu SL, Liu Y, X.Wang G, Luo ZJ, Tang XL, Chen G, Huo YN, Gao ZN, Su Q, Z.Ye, Wang YM, Qin GJ, Deng HC, Yu XF, Shen FX, Chen L, B.Zhao L, Wang TG, Lai SH, Li D, Wang WQ, Ning G. Associations of depression with impaired glucose regulation, newly diagnosed diabetes and previously diagnosed diabetes in Chinese adults. Diabetic Medicine 32:935-43, 2015.
94. Luo Z, Li Y, Wang H, Fleming J, Li M, Kang Y, Zhang R, Li D. Hepatocyte Nuclear Factor 1A (HNF1A) as a Possible Tumor Suppressor in Pancreatic Cancer. PLoS One 10(3):e0121082, 2015. e-Pub 2015. PMID: 25793983.
95. Arem H, Yu K, Xiong X, Moy K, Freedman ND, Mayne ST, Albanes D, Amundadottir LT, Arslan AA, Austin M, Bamlet WR, Beane-Freeman L, Bracci P, Canzian F, Chanock SJ, Cotterchio M, Duell EJ, Gallinger S, Giles GG, Goggins M, Goodman PJ, Hartge P, Hassan M, Helzlsouer K, Henderson B, Holly EA, Hoover R, Jacobs EJ, Kamineni A, Klein A, Klein E, Kolonel LN, Li D, Malats N, Männistö S, McCullough ML, Olson SH, Orlow I, Peters U, Petersen GM, Porta M, Severi G, Shu XO, Van Den Eeden S, Visvanathan K, White E, Yu H, Zeleniuch-Jacquotte A, Zheng W, Tobias GS, Maeder D, Brotzman M, Risch H, Sampson JN, Stolzenberg-Solomon RZ. Correction: Vitamin D Metabolic Pathway Genes and Pancreatic Cancer Risk. PLoS One 10(6):e0129983, 2015. e-Pub 2015. PMID: 26039095.
96. Wang Y, Li D, Wei P. Powerful Tukey's One Degree-of-Freedom Test for Detecting Gene-Gene and Gene-Environment Interactions. Cancer Inform 14(Suppl 2):209-18, 2015. e-Pub 2015. PMID: 26064040.
97. Zuo M, Rashid A, Churi C, Vauthey JN, Chang P, Li Y, Hung M-C, Li D, Javle M. Novel therapeutic strategy targeting the Hedgehog signaling and mTOR pathways in biliary tract cancer. Br J Cancer 112:1042-51, 2015.
98. Li D, Mao Y, Chang P, Liu C, Hassan MM, Yeung SJ, Abbruzzese JL. Impacts of new-onset and long-term diabetes on clinical outcome of pancreatic cancer. Am J Cancer Res 5(10):3260-9, 2015. e-Pub 2015. PMID: 26693076.
99. Wang Z, Zhu B, Zhang M, Parikh H, Jia J, Chung CC, Sampson JN, Hoskins JW, Hutchinson A, Burdette L, Ibrahim A, Hautman C, Raj PS, Abnet CC, Adjei AA, Ahlbom A, Albanes D, Allen NE, Ambrosone CB, Aldrich M, Amiano P, Amos C, Andersson U, Andriole G, Andrulis IL, Arici C, Arslan AA, Austin MA, Baris D, Barkauskas DA, Bassig BA, Beane Freeman LE, Berg CD, Berndt SI, Bertazzi PA, Biritwum RB, Black A, Blot W, Boeing H, Boffetta P, Bolton K, Boutron-Ruault MC, Bracci PM, Brennan P, Brinton LA, Brotzman M, Bueno-de-Mesquita HB, Buring JE, Butler MA, Cai Q, Cancel-Tassin G, Canzian F, Cao G, Caporaso NE, Carrato A, Carreon T, Carta A, Chang GC, Chang IS, Chang-Claude J, Che X, Chen CJ, Chen CY, Chen CH, Chen C, Chen KY, Chen YM, Chokkalingam AP, Chu LW, Clavel-Chapelon F, Colditz GA, Colt JS, Conti D, Cook MB, Cortessis VK, Crawford ED, Cussenot O, Davis FG, De Vivo I, Deng X, Ding T, Dinney CP, Di Stefano AL, Diver WR, Duell EJ, Elena JW, Fan JH, Feigelson HS, Feychting M, Figueroa JD, Flanagan AM, Fraumeni JF, Freedman ND, Fridley BL, Fuchs CS, Gago-Dominguez M, Gallinger S, Gao YT, Gapstur SM, Garcia-Closas M, Garcia-Closas R, Gastier-Foster JM, Gaziano JM, Gerhard DS, Giffen CA, Giles GG, Gillanders EM, Giovannucci EL, Goggins M, Gokgoz N, Goldstein AM, Gonzalez C, Gorlick R, Greene MH, Gross M, Grossman HB, Grubb R, Gu J, Guan P, Haiman CA, Hallmans G, Hankinson SE, Harris CC, Hartge P, Hattinger C, Hayes RB, He Q, Helman L, Henderson BE, Henriksson R, Hoffman-Bolton J, Hohensee C, Holly EA, Hong YC, Hoover RN, Hosgood HD, Hsiao CF, Hsing AW, Hsiung CA, Hu N, Hu W, Hu Z, Huang MS, Hunter DJ, Inskip PD, Ito H, Jacobs EJ, Jacobs KB, Jenab M, Ji BT, Johansen C, Johansson M, Johnson A, Kaaks R, Kamat AM, Kamineni A, Karagas M, Khanna C, Khaw KT, Kim C, Kim IS, Kim JH, Kim YH, Kim YC, Kim YT, Kang CH, Jung YJ, Kitahara CM, Klein AP, Klein R, Kogevinas M, Koh WP, Kohno T, Kolonel LN, Kooperberg C, Kratz CP, Krogh V, Kunitoh H, Kurtz RC, Kurucu N, Lan Q, Lathrop M, Lau CC,. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. Hum Mol Genet 23(24):6616-33, 2014. e-Pub 2014. PMID: 25027329.
100. Wei P, Tang H, Li D. Functional logistic regression approach to detecting gene by longitudinal environmental exposure interaction in a case-control study. Genet Epidemiol 38(7):638-51, 2014. e-Pub 2014. PMID: 25219575.
101. Wolpin BM, Rizzato C, Kraft P, Kooperberg C, Petersen GM, Wang Z, Arslan AA, Beane-Freeman L, Bracci PM, Buring J, Canzian F, Duell EJ, Gallinger S, Giles GG, Goodman GE, Goodman PJ, Jacobs EJ, Kamineni A, Klein AP, Kolonel LN, Kulke MH, Li D, Malats N, Olson SH, Risch HA, Sesso HD, Visvanathan K, White E, Zheng W, Abnet CC, Albanes D, Andreotti G, Austin MA, Barfield R, Basso D, Berndt SI, Boutron-Ruault MC, Brotzman M, Büchler MW, Bueno-de-Mesquita HB, Bugert P, Burdette L, Campa D, Caporaso NE, Capurso G, Chung C, Cotterchio M, Costello E, Elena J, Funel N, Gaziano JM, Giese NA, Giovannucci EL, Goggins M, Gorman MJ, Gross M, Haiman CA, Hassan M, Helzlsouer KJ, Henderson BE, Holly EA, Hu N, Hunter DJ, Innocenti F, Jenab M, Kaaks R, Key TJ, Khaw KT, Klein EA, Kogevinas M, Krogh V, Kupcinskas J, Kurtz RC, LaCroix A, Landi MT, Landi S, Le Marchand L, Mambrini A, Mannisto S, Milne RL, Nakamura Y, Oberg AL, Owzar K, Patel AV, Peeters PH, Peters U, Pezzilli R, Piepoli A, Porta M, Real FX, Riboli E, Rothman N, Scarpa A, Shu XO, Silverman DT, Soucek P, Sund M, Talar-Wojnarowska R, Taylor PR, Theodoropoulos GE, Thornquist M, Tjønneland A, Tobias GS, Trichopoulos D, Vodicka P, Wactawski-Wende J, Wentzensen N, Wu C, Yu H, Yu K, Zeleniuch-Jacquotte A, Hoover R, Hartge P, Fuchs C, Chanock SJ, Stolzenberg-Solomon RS, Amundadottir LT. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Nat Genet 46(9):994-1000, 2014. e-Pub 2014. PMID: 25086665.
102. Tang H, Wei P, Duell EJ, Risch HA, Olson SH, Bueno-de-Mesquita HB, Gallinger S, Holly EA, Petersen G, Bracci PM, McWilliams RR, Jenab M, Riboli E, Tjønneland A, Boutron-Ruault MC, Kaaks R, Trichopoulos D, Panico S, Sund M, Peeters PH, Khaw KT, Amos CI, Li D. Axonal guidance signaling pathway interacting with smoking in modifying the risk of pancreatic cancer: a gene- and pathway-based interaction analysis of GWAS data. Carcinogenesis 35(5):1039-45, 2014. e-Pub 2014. PMID: 24419231.
103. Bi Y, Lu J, Wang W, Mu Y, Zhao J, Liu C, Chen L, Shi L, Li Q, Wan Q, Wu S, Yang T, Yan L, Liu Y, Wang G, Luo Z, Tang X, Chen G, Huo Y, Gao Z, Su Q, Ye Z, Wang Y, Qin G, Deng H, Yu X, Shen F, Chen L, Zhao L, Zhang J, Sun J, Dai M, Xu M, Xu Y, Chen Y, Lai S, Bloomgarden ZT, Li D, Ning G. Cohort Profile: Risk evaluation of cancers in Chinese diabetic Individuals: a longitudinal (REACTION) study. J Diabetes 6(2):147-57, 2014. e-Pub 2014. PMID: 24237858.
104. Tang H, Wei P, Duell EJ, Risch HA, Olson SH, Bueno-de-Mesquita HB, Gallinger S, Holly EA, Petersen GM, Bracci PM, McWilliams RR, Jenab M, Riboli E, Tjønneland A, Boutron-Ruault MC, Kaaks R, Trichopoulos D, Panico S, Sund M, Peeters PH, Khaw KT, Amos CI, Li D. Genes-environment interactions in obesity-and diabetes-associated pancreatic cancer: A GWAS data analysis. Cancer Epidemiol Biomarkers Prev 23(1):98-106, 2014. e-Pub 2013. PMID: 24136929.
105. Javle M, Li Y, Tan D, Dong X, Chang P, Kar S, Li D. Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer. PLoS One 9(1):e85942, 2014. e-Pub 2014. PMID: 24465802.
106. Bosetti C, Rosato V, Li D, Silverman D, Petersen G, Bracci, PM, Neale RE, Muscat J, Anderson K, Gallinger S, Olson SH, Miller AB, Bas Bueno-de-Mesquita H, Scelo G, Janout V, Holcatova I, Lagiou P, Serraino D, Lucenteforte E, Fabianova E, Ghadirian P, Baghurst PA, Zatonski W, Foretova L, Fontham E, Bamlet WR, Holly EA, Negri E, Hassan M, Prizment A, Cotterchio M, Clear S, Kurtz RA, Maisonneuve P, Trichopoulos D, Polesel J, Duell EJ, Boffetta P, La Vecchia C. Diabetes, Antidiabetic Medications and Pancreatic Cancer Risk: An analysis from the International Pancreatic Cancer Case-Control Consortium. Ann Onc 25(10):2065-72, 2014.
107. Hassan MM, Kaseb A, Etzel CJ, El-Serag H, Spitz MR, Chang P, Hale KS, Liu M, Rashid A, Shama M, Abbruzzese JL, Loyer EM, Kaur H, Hassabo HM, Vauthey JN, Wray CJ, Hassan BS, Patt YZ, Hawk E, Soliman KM, Li D. Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: Risk and prognosis prediction. Mol Carcinog 52 Suppl 1:139-47, 2013. e-Pub 2013. PMID: 23776098.
108. Leenders M, Bhattacharjee S, Vineis P, Stevens V, Bueno-de-Mesquita HB, Shu XO, Amundadottir L, Gross M, Tobias GS, Wactawski-Wende J, Arslan AA, Duell EJ, Fuchs CS, Gallinger S, Hartge P, Hoover RN, Holly EA, Jacobs EJ, Klein AP, Kooperberg C, LaCroix A, Li D, Mandelson MT, Olson SH, Petersen G, Risch HA, Yu K, Wolpin BM, Zheng W, Agalliu I, Albanes D, Boutron-Ruault MC, Bracci PM, Buring JE, Canzian F, Chang K, Chanock SJ, Cotterchio M, Gaziano JM, Giovanucci EL, Goggins M, Hallmans G, Hankinson SE, Hoffman-Bolton JA, Hunter DJ, Hutchinson A, Jacobs KB, Jenab M, Khaw KT, Kraft P, Krogh V, Kurtz RC, McWilliams RR, Mendelsohn JB, Patel AV, Rabe KG, Riboli E, Tjønneland A, Trichopoulos D, Virtamo J, Visvanathan K, Elena JW, Yu H, Zeleniuch-Jacquotte A, Stolzenberg-Solomon RZ. Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4. Cancer Causes Control 24(3):595-602, 2013. e-Pub 2013. PMID: 23334854.
109. Chen Y, Lu J, Huang Y, Wang T, Xu Y, Xu M, Li M, Wang W, Li D, Bi Y, Ning G. Association of previous schistosome infection with diabetes and metabolic syndrome: a cross-sectional study in rural China. J Clin Endocrinol Metab 98(2):E283-7, 2013. e-Pub 2012. PMID: 23275524.
110. Chen Y, Lu J, Huang Y, Bi Y, Xu M, Xu Y, Wang T, Li M, Li D, Ning G. History of Schistosome Infection, Metabolic Profiles and Risk of Diabetic Mellitus: A cross sectional study in rural China. J Clin Endoc Met 98:E283-7, 2013. PMID: 23275524.
111. Klein AP, Lindström S, Mendelsohn JB, Steplowski E, Arslan AA, Bueno-de-Mesquita HB, Fuchs CS , Gallinger S , Gross M, Helzlsouer K, Holly EA, Jacobs EJ, LaCroix A, Li D, Mandelson MT, Olson SH, Petersen G, Risch HA, Stolzenberg-Solomon RZ, Zheng W, Amundadottir L, Albanes D, Allen NE, Bamlet WR, Boutron-Ruault MC, Buring JE, Bracci PM, Canzian F, Chanock SJ, Clipp S, Cotterchio M, Duell EJ, Gaziano JM, Giovannucci EL, Goggins M, Hallmans G, Hankinson SE, Hassan M, Hutchinson A, Hunter DJ, Kooperberg C, Kurtz RC, Liu S, Overvad K, Palli D, Patel AV, Rabe KG, Shu XO, Slimani N, Tobias GS, Trichopoulos D, Van Den Eeden SK, Vineis P, Virtamo J, Wactawski-Wende J, Watters JL, Wolpin NM, Yu H, Yu K, Zeleniuch-Jacquotte A, Hoover RN, Hartge P, Kraft P. An Absolute Risk Model for Identifying Individuals at Elevated Risk for Pancreatic Cancer in the General Population. PLoS ONE 8:e72311, 2013.
112. Li D, Duell EJ, Yu K, Risch HA, Olson SH, Kooperberg C, Wolpin BM, Jiao L, Dong X, Wheeler B, Arslan AA, Bueno-de-Mesquita HB, Fuchs CS, Gallinger S, Gross M, Hartge P, Hoover RN, Holly EA, Jacobs EJ, Klein AP, LaCroix A, Mandelson MT, Petersen G, Zheng W, Agalliu I, Albanes D, Boutron-Ruault MC, Bracci PM, Buring JE, Canzian F, Chang K, Chanock SJ, Cotterchio M, Gaziano JM, Giovannucci EL, Goggins M, Hallmans G, Hankinson SE, Hoffman Bolton JA, Hunter DJ, Hutchinson A, Jacobs KB, Jenab M, Khaw KT, Kraft P, Krogh V, Kurtz RC, McWilliams RR, Mendelsohn JB, Patel AV, Rabe KG, Riboli E, Shu XO, Tjønneland A, Tobias GS, Trichopoulos D, Virtamo J, Visvanathan K, Watters J, Yu H, Zeleniuch-Jacquotte A, Amundadottir L, Stolzenberg-Solomon RZ. Pathway Analysis of Genome-wide Association Study Data Highlights Pancreatic Development Genes as Susceptibility Factors for Pancreatic Cancer. Carcinogenesis 33(7):1384-90, 2012. e-Pub 2012. PMID: 22523087.
113. Dong X, Li Y, Chang P, Hess KR, Abbruzzese JL, Li D. DNA mismatch repair network gene polymorphism as a susceptibility factor for pancreatic cancer. Mol Carcinog 51(6):491-9, 2012. e-Pub 2011. PMID: 21681824.
114. Jacobs KB, Yeager M, Zhou W, Wacholder S, Wang Z, Rodriguez-Santiago B, Hutchinson A, Deng X, Liu C, Horner MJ, Cullen M, Epstein CG, Burdett L, Dean MC, Chatterjee N, Sampson J, Chung CC, Kovaks J, Gapstur SM, Stevens VL, Teras LT, Gaudet MM, Albanes D, Weinstein SJ, Virtamo J, Taylor PR, Freedman ND, Abnet CC, Goldstein AM, Hu N, Yu K, Yuan JM, Liao L, Ding T, Qiao YL, Gao YT, Koh WP, Xiang YB, Tang ZZ, Fan JH, Aldrich MC, Amos C, Blot WJ, Bock CH, Gillanders EM, Harris CC, Haiman CA, Henderson BE, Kolonel LN, Le Marchand L, McNeill LH, Rybicki BA, Schwartz AG, Signorello LB, Spitz MR, Wiencke JK, Wrensch M, Wu X, Zanetti KA, Ziegler RG, Figueroa JD, Garcia-Closas M, Malats N, Marenne G, Prokunina-Olsson L, Baris D, Schwenn M, Johnson A, Landi MT, Goldin L, Consonni D, Bertazzi PA, Rotunno M, Rajaraman P, Andersson U, Beane Freeman LE, Berg CD, Buring JE, Butler MA, Carreon T, Feychting M, Ahlbom A, Gaziano JM, Giles GG, Hallmans G, Hankinson SE, Hartge P, Henriksson R, Inskip PD, Johansen C, Landgren A, McKean-Cowdin R, Michaud DS, Melin BS, Peters U, Ruder AM, Sesso HD, Severi G, Shu XO, Visvanathan K, White E, Wolk A, Zeleniuch-Jacquotte A, Zheng W, Silverman DT, Kogevinas M, Gonzalez JR, Villa O, Li D, Duell EJ, Risch HA, Olson SH, Kooperberg C, Wolpin BM, Jiao L, Hassan M, Wheeler W, Arslan AA, Bueno-de-Mesquita HB, Fuchs CS, Gallinger S, Gross MD, Holly EA, Klein AP, LaCroix A, Mandelson MT, Petersen G, Boutron-Ruault MC, Bracci PM, Canzian F, Chang K, Cotterchio M, Giovannucci EL, Goggins M, Hoffman Bolton JA, Jenab M, Khaw KT, Krogh V, Kurtz RC, McWilliams RR, Mendelsohn JB, Rabe KG, Riboli E, Tjønneland A, Tobias GS, Trichopoulos D, Elena JW, Yu H, Amundadottir L, Stolzenberg-Solomon RZ, Kraft P, Schumacher F, Stram D, Savage SA, Mirabello L, Andrulis IL, Wunder JS, Patiño García A, Sierrasesúmaga L, Barkauskas DA, Gorlick RG, Purdue M, Chow WH, Moore LE, Schwartz KL, Davis FG, Hsing AW, Berndt SI, Black A, Wentzensen N, Brinton LA, Lissowska J, Peplonska. Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet 44(6):651-8, 2012. e-Pub 2012. PMID: 22561519.
115. Sadeghi N, Abbruzzese JL, Yeung SC, Hassan M, Li D. Metformin use is associated with better survival of diabetic patients with pancreatic cancer. Clin Cancer Res 18(10):2905-12, 2012. e-Pub 2012. PMID: 22465831.
116. Dong X, Li Y, Tang H, Chang P, Hess KR, Abbruzzese JL, Li D. Insulin-like Growth Factor Axis Gene Polymorphisms Modify Risk of Pancreatic Cancer. Cancer Epidemiol 36(2):206-11, 2012. e-Pub 2011. PMID: 21852217.
117. Li D. Diabetes and Pancreatic Cancer. Mol Carcinog 51(1):64-74, 2012. PMID: 22162232.
118. Yu H, Zhao H, Wang LE, Liu Z, Li D, Wei Q. Correlation between base-excision repair gene polymorphisms and levels of in-vitro BPDE-induced DNA adducts in cultured peripheral blood lymphocytes. PLoS One 7(7):e40131, 2012. e-Pub 2012. PMID: 22792228.
119. Wei P, Tang H, Li D. Insights into pancreatic cancer etiology from pathway analysis of genome-wide association study data. PLoS One 7(10):e46887, 2012. e-Pub 2012. PMID: 23056513.
120. Duell EJ, Lucenteforte E, Olson SH, Bracci PM, Li D, Risch HA, Silverman D, Ji B-T, Gallinger S, Holly EA, Fontham ETH, Maisonneuve P, Bueno-de-Mesquita HB, Ghadirian P, Kurtz RC, Ludwig E, Yu H, Lowenfels AB, Seminara D, Petersen G, La Vecchia C, Boffetta P. Pancreatitis History and Pancreas Cancer Risk: A Pooled Analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol 23(11):2964-70, 2012.
121. Sahin IH, Shama MA, Tanaka M, Abbruzzese JL, Curley SA, Hassan M, Li D. Association of diabetes and perineural invasion in pancreatic cancer. Cancer Science 1(3):357-362, 2012.
122. Lucenteforte E, La Vecchia C, Silverman D, Petersen GM, Bracci PM, Ji BT, Bosetti C, Li D, Gallinger S, Miller AB, Bueno-de-Mesquita HB, Talamini R, Polesel J, Ghadirian P, Baghurst PA, Zatonski W, Fontham E, Bamlet WR, Holly EA, Gao YT, Negri E, Hassan M, Cotterchio M, Su J, Maisonnueve P, Boffetta P, Duell EJ. Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Annals Oncol 23(2):374-82, 2012.
123. Bosetti C, Lucenteforte E, Silverman DT, Petersen G, Bracci PM, Ji BT, Negri E, Li D, Risch HA, Olson SH, Gallinger S, Miller AB, Bueno-de-Mesquita HB, Talamini R, Polesel J, Ghadirian P, Baghurst PA, Zatonski W, Fontham E, Bamlet WR, Holly EA, Bertuccio P, Gao YT, Hassan M, Yu H, Kurtz RC, Cotterchio M, Su J, Maisonneuve P, Duell EJ, Boffetta P, La Vecchia C. Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol 23(7):1880-8, 2012.
124. Li D. Metformin as an Antitumor Agent in Cancer Prevention and Treatment. J Diabetes 3(4):320-7, 2011. e-Pub 2011. PMID: 21631893.
125. Zhou G, Gingras MC, Liu SH, Li D, Li Z, Catania RL, Stehling KM, Li M, Paganelli G, Gibbs RA, Demayo FJ, Fisher WE, Brunicardi FC. The Hypofunctional Effect of P335L Single Nucleotide Polymorphism on SSTR5 Function. World J Surg 35(8):1715-24, 2011. e-Pub 2011. PMID: 21249361.
126. Tanaka M, Chang P, Li Y, Li D, Overman M, Maru DM, Sethi S, Phillips J, Bland GL, Abbruzzese JL, Eng C. Association of CHFR Promoter Methylation with Disease Recurrence in Locally Advanced Colon Cancer. Clin Cancer Res 17(13):4531-40, 2011. e-Pub 2011. PMID: 21551253.
127. Li D, Tanaka M, Brunicardi FC, Fisher WE, Gibbs RA, Gingras MC. Association between somatostatin receptor 5 gene polymorphisms and pancreatic cancer risk and survival. Cancer 117(13):2863-72, 2011. e-Pub 2011. PMID: 21692047.
128. Tang H, Dong X, Hassan M, Abbruzzese JL, Li D. Body Mass Index and Obesity- and Diabetes-associated Genes and Risk for Pancreatic Cancer. Cancer Epidemiol Biomarkers Prev 20(5):779-92, 2011. e-Pub 2011. PMID: 21357378.
129. Dong X, Li Y, Chang P, Tang H, Hess KR, Abbruzzese JL, Li D. Glucose Metabolism Gene Variations Modulate the Risk of Pancreatic Cancer. Cancer Prev Res (Phila) 4(5):758-66, 2011. e-Pub 2011. PMID: 21411499.
130. Dong X, Tang H, Hess KR, Abbruzzese JL, Li D. Glucose metabolism gene polymorphisms and clinical outcome in pancreatic cancer. Cancer 117(3):480-91, 2011. e-Pub 2010. PMID: 20845477.
131. Tanaka M, Okazaki T, Suzuki H, Abbruzzese JL, Li D. Association of multi-drug resistance gene polymorphisms with pancreatic cancer outcome. Cancer 117(4):744-51, 2011. e-Pub 2010. PMID: 20922799.
132. Chang P, Li Y, Li D. Micronuclei Levels in Peripheral Blood Lymphocytes as a Potential Biomarker for Pancreatic Cancer Risk. Carcinogenesis 32(2):210-5, 2011. e-Pub 2010. PMID: 21097528.
133. Li D, Tang H, Hassan MM, Holly EA, Bracci PM, Silverman DT. Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies. Cancer Causes Control 22(2):189-97, 2011. e-Pub 2010. PMID: 21104117.
134. Dong X, Li Y, Hess KR, Abbruzzese JL, Li D. DNA Mismatch Repair Gene Polymorphisms Affect Survival in Pancreatic Cancer. Oncologist 16(1):61-70, 2011. e-Pub 2011. PMID: 21212431.
135. Bertuccio P, Vecchia CL, Silverman D, Petersen G, Bracci PM, Negri E, Li D, Risch HA, Olsoon SH, Gallinger S, Miller AB, Bueno-de-Mesquita HB, Talamini R, Polesel J, Ghadirian P, Baghurst PA, Zatonski W, Fontham E, Bamlet WR, Holly EA, Lucenteforte E, Hassan M, Yu H, Kurtz RC, Cotterchio M, Su J, Maisonneuve P, Duell EJ, Bosetti C, Boffetta P. Cigar and pipe-smoking, smokeless tobacco use and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol 22(6):1420-6, 2011.
136. Tanaka M, Javle M, Dong X, Eng C, Abbruzzese JL, Li D. Gemcitabine Metabolic and Transporter Gene Polymorphisms Are Associated with Drug Toxicity and Efficacy in Patients with Locally Advanced Pancreatic Cancer. Cancer 116(22):5325-35, 2010. e-Pub 2010. PMID: 20665488.
137. Dong X, Javle M, Hess KR, Shroff R, Abbruzzese JL, Li D. Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancer. Gastroenterology 139(2):464-73, 473.e1-3, 2010. e-Pub 2010. PMID: 20416304.
138. Hassan MM, Curley SA, Li D, Kaseb A, Davila M, Abdalla EK, Javle M, Moghazy DM, Lozano RD, Abbruzzese JL, Vauthey JN. Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma. Cancer 116(8):1938-46, 2010. e-Pub 2010. PMID: 20166205.
139. Tang H, Dong X, Day RS, Hassan MM, Li D. Antioxidant Genes, Diabetes and Dietary Antioxidants in Association with Risk of Pancreatic Cancer. Carcinogenesis 31(4):607-13, 2010. e-Pub 2010. PMID: 20097730.
140. Petersen GM, Amundadottir L, Fuchs CS, Kraft P, Stolzenberg-Solomon RZ, Jacobs KB, Arslan AA, Bueno-de-Mesquita HB, Gallinger S, Gross M, Helzlsouer K, Holly EA, Jacobs EJ, Klein AP, LaCroix A, Li D, Mandelson MT, Olson SH, Risch HA, Zheng W, Albanes D, Bamlet WR, Berg CD, Boutron-Ruault MC, Buring JE, Bracci PM, Canzian F, Clipp S, Cotterchio M, de Andrade M, Duell EJ, Gaziano JM, Giovannucci EL, Goggins M, Hallmans G, Hankinson SE, Hassan M, Howard B, Hunter DJ, Hutchinson A, Jenab M, Kaaks R, Kooperberg C, Krogh V, Kurtz RC, Lynch SM, McWilliams RR, Mendelsohn JB, Michaud DS, Parikh H, Patel AV, Peeters PH, Rajkovic A, Riboli E, Rodriguez L, Seminara D, Shu XO, Thomas G, Tjønneland A, Tobias GS, Trichopoulos D, Van Den Eeden SK, Virtamo J, Wactawski-Wende J, Wang Z, Wolpin BM, Yu H, Yu K, Zeleniuch-Jacquotte A, Fraumeni JF, Hoover RN, Hartge P, Chanock SJ. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet 42(3):224-8, 2010. e-Pub 2010. PMID: 20101243.
141. Okazaki T, Javle M, Tanaka M, Abbruzzese JL, Li D. Single nucleotide polymorphisms of gemcitabine metabolic genes and pancreatic cancer survival and drug toxicity. Clin Cancer Res 16(1):320-9, 2010. e-Pub 2009. PMID: 20028759.
142. Bracci PM, Wang F, Hassan MM, Gupta S, Li D, Holly EA. Pancreatitis and pancreatic cancer in two large pooled case-control studies. Cancer Causes Control 20(9):1723-1731, 2009. PMID: 19760029.
143. Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Jacobs EJ, LaCroix A, Zheng W, Albanes D, Bamlet W, Berg CD, Berrino F, Bingham S, Buring JE, Bracci PM, Canzian F, Clavel-Chapelon F, Clipp S, Cotterchio M, de Andrade M, Duell EJ, Fox JW, Gallinger S, Gaziano JM, Giovannucci EL, Goggins M, González CA, Hallmans G, Hankinson SE, Hassan M, Holly EA, Hunter DJ, Hutchinson A, Jackson R, Jacobs KB, Jenab M, Kaaks R, Klein AP, Kooperberg C, Kurtz RC, Li D, Lynch SM, Mandelson M, McWilliams RR, Mendelsohn JB, Michaud DS, Olson SH, Overvad K, Patel AV, Peeters PH, Rajkovic A, Riboli E, Risch HA, Shu XO, Thomas G, Tobias GS, Trichopoulos D, Van Den Eeden SK, Virtamo J, Wactawski-Wende J, Wolpin BM, Yu H, Yu K, Zeleniuch-Jacquotte A, Chanock SJ, Hartge P, Hoover RN. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet 41(9):986-90, 2009. e-Pub 2009. PMID: 19648918.
144. Wang J, Chen J, Chang P, LeBlanc A, Li D, Abbruzzesse JL, Frazier ML, Killary AM, Sen S. MicroRNAs in Plasma of Pancreatic Ductal Adenocarcinoma Patients as Novel Blood Based Biomarkers of Disease. Cancer Prev Res (Phila Pa) 2(9):807-13, 2009. e-Pub 2009. PMID: 19723895.
145. Li D, Yeung SC, Hassan MM, Konopleva M, Abbruzzese JL. Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology 137(2):482-8, 2009. e-Pub 2009. PMID: 19375425.
146. Cotton RT, Li D, Scherer SE, Muzny DM, Hodges SE, Catania RL, Witkiewicz AK, Brody JR, Kennedy EP, Yeo CJ, Brunicardi FC, Gibbs RA, Gingras MC, Fisher WE. Single nucleotide polymorphism in RECQL and survival in resectable pancreatic adenocarcinoma. HPB (Oxford) 11(5):435-444, 2009. e-Pub 2009. PMID: 19768149.
147. Eng-Wong J, Perkins SN, Bondy M, Li D, Eva Singletary S, Núñez N, Hursting S, Chang S. Premenopausal breast cancer; estrogen receptor status and insulin-like growth factor-I (IGF-I), insulin-like growth factor binding protein-3 (IGFBP-3) and leptin. Breast J 15(4):426-8, 2009. PMID: 19601950.
148. Li D, Morris JS, Liu J, Hassan MM, Day RS, Bondy ML, Abbruzzese JL. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA 301(24):2553-62, 2009. PMID: 19549972.
149. Hassan MM, Kaseb A, Li D, Patt YZ, Vauthey JN, Thomas MB, Curley SA, Spitz MR, Sherman SI, Abdalla EK, Davila M, Lozano RD, Hassan DM, Chan W, Brown TD, Abbruzzese JL. Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States. Hepatology 49(5):1563-70, 2009. PMID: 19399911.
150. Dong X, Jiao L, Li Y, Evans DB, Wang H, Hess KR, Abbruzzese JL, Li D. Significant associations of mismatch repair gene polymorphisms with clinical outcome of pancreatic cancer. J Clin Oncol 27(10):1592-9, 2009. e-Pub 2009. PMID: 19237629.
151. Chen J, Li D, Killary AM, Sen S, Amos CI, Evans DB, Abbruzzese JL, Frazier ML. Polymorphisms of p16, p27, p73, and MDM2 modulate response and survival of pancreatic cancer patients treated with preoperative chemoradiation. Ann Surg Oncol 16(2):431-9, 2009. e-Pub 2008. PMID: 19020940.
152. Hassan MM, Spitz MR, Thomas MB, Curley SA, Patt YZ, Vauthey JN, Glover KY, Kaseb A, Lozano RD, El-Deeb AS, Nguyen NT, Wei SH, Chan W, Abbruzzese JL, Li D. The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States. J Hepatol 50(2):334-41, 2009. e-Pub 2008. PMID: 19070394.
153. Li D, Suzuki H, Liu B, Morris J, Liu J, Okazaki T, Li Y, Chang P, Abbruzzese JL. DNA Repair Gene Polymorphisms and Risk of Pancreatic Cancer. Clin Cancer Res 15(2):740-6, 2009. PMID: 19147782.
154. Suzuki H, Li Y, Dong X, Hassan MM, Abbruzzese JL, Li D. Effect of insulin-like growth factor gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 17(12):3467-73, 2008. PMID: 19064563.
155. Hassan MM, Spitz MR, Thomas MB, El-Deeb AS, Glover KY, Nguyen NT, Chan W, Kaseb A, Curley SA, Vauthey J-N, Ellis LM, Abdalla E, Lozano RD, Patt YZ, Brown TD, Abbruzzeze JL, Li D. Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: Case-control study. Int J Cancer 123(8):1883-1891, 2008. PMID: 18688864.
156. Hassan MM, Li D, El-Deeb AS, Wolff RA, Bondy ML, Davila M, Abbruzzese JL. Association between hepatitis B virus and pancreatic cancer. J Clin Oncol 26(28):4557-62, 2008. PMID: 18824707.
157. Hassan M, Phan A, Dagohoy C, Li D, Yao J.. Risk Factors Associated with Neuroendocrine Tumors: A U.S.-Based Case-Control Study. Int J Cancer 123(4):867-73, 2008. PMID: 18491401.
158. Zhao H, Wang LE, Li D, Chamberlain RM, Sturgis EM, Wei Q. Genotypes and haplotypes of ERCC1 and ERCC2/XPD genes predict levels of benzo[a]pyrene diol epoxide-induced DNA adducts in cultured primary lymphocytes from healthy individuals: a genotype-phenotype correlation analysis. Carcinogenesis 29(8):1560-6, 2008. e-Pub 2008. PMID: 18635523.
159. Suzuki H, Jiao L, Li Y, Doll MA, Hein DW, Hassan MM, Day RS, Bondy ML, Abbruzzese JL and Li D.. Interaction of the Cytochrome P4501A2, SULT1A1 and NAT gene Polymorphisms with Smoking and Dietary Mutagen Intake in Modification of the Risk of Pancreatic Cancer. Carcinogenesis 29(6):1184-1191, 2008. e-Pub 2008. PMID: 18499698.
160. Okazaki T, Jiao L, Chang P, Evans DB, Abbruzzese JL, Li D. Single Nucleotide Polymorphisms of DNA Damage Response Genes Are Associated with Overall Survival in Patients with Pancreatic Cancer. Clin Cancer Res 14(7):2042-8, 2008. PMID: 18381943.
161. Hassan MM, Phan A, Li D, Dagohoy CG, Leary C, Yao JC. Family history of cancer and associated risk of developing neuroendocrine tumors: a case-control study. Cancer Epidemiol Biomarkers Prev 17(4):959-65, 2008. PMID: 18398037.
162. Jiao L, Hassan MM, Bondy ML, Wolff RA, Evans DB, Abbruzzese JL, Li D. XRCC2 and XRCC3 Gene Polymorphism and Risk of Pancreatic Cancer. Am J Gastroenterol 103(2):360-7, 2008. e-Pub 2007. PMID: 17986315.
163. Hu Y, Li G, Xue X, Zhou Z, Li X, Fu J, Cohen B, Roy N, Li D, Sun J, Nan P, Tang MS, Qu Q.. PAH-DNA adducts in a Chinese population: Relationship to PAH exposure, smoking, and polymorphisms of metabolic and DNA repair genes. Biomarkers 13(1):27-40, 2008. PMID: 17896209.
164. White DL, Li D, Nurgalieva Z, El-Serag HB. Genetic variants of glutathione S-transferase as possible risk factors for hepatocellular carcinoma: a HuGE systematic review and meta-analysis. Am J Epidemiol 167(4):377-89, 2008. e-Pub 2007. PMID: 18065725.
165. Hassan MM, Bondy ML, Wolff RA, Abbruzzese JL, Vauthey JN, Pisters PW, Evans DB, Khan R, Chou TH, Lenzi R, Jiao L, Li D. Risk factors for pancreatic cancer: case-control study. Am J Gastroenterol 102(12):2696-707, 2007. e-Pub 2007. PMID: 17764494.
166. Jiao L, Doll MA, Hein DW, Bondy ML, Hassan MM, Hixson JE, Abbruzzese JL and Li D. Haplotype of N-acetyltransferase 1 and 2 and Risk of Pancreatic Cancer. Cancer Epidemiol Biomarkers Prev 16(11):2379-2386, 2007. PMID: 18006927.
167. Kawamoto T, Krishnamurthy S, Tarco E, Trivedi S, Wistuba II, Li D, Roa I, Roa JC, Thomas MB. HER Receptor Family: Novel Candidate for Targeted Therapy for Gallbladder and Extrahepatic Bile Duct Cancer. Gastrointest Cancer Res 1(6):221-7, 2007. PMID: 19262900.
168. Lin EH, Hassan M, Li Y, Zhao H, Nooka A, Sorenson E, Xie K, Champlin R, Wu X, Li D. Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence. Cancer 110(3):534-42, 2007. PMID: 17594720.
169. Li D, Wang LE, Chang P, el-Naggar AK, Sturgis EM, Wei Q. In Vitro Benzo[a]pyrene Diol Epoxide-Induced DNA Adducts and Risk of Squamous Cell Carcinoma of Head and Neck. Cancer Res 67(12):5628-5634, 2007. PMID: 17575128.
170. Hassan MM, Abbruzzese JL, Bondy ML, Wolff RA, Vauthey JN, Pisters PW, Evans DB, Khan R, Lenzi R, Jiao L, Li D. Passive smoking and the use of noncigarette tobacco products in association with risk for pancreatic cancer: a case-control study. Cancer 109(12):2547-56, 2007. PMID: 17492688.
171. Chen J, Li D, Wei C, Sen S, Killary AM, Amos CI, Evans DB, Abbruzzese JL, Frazier ML. Aurora-A and p16 Polymorphisms Contribute to an Earlier Age at Diagnosis of Pancreatic Cancer in Caucasians. Clin Cancer Res 13(10):3100-3104, 2007. PMID: 17505013.
172. Li D, Liu H, Jiao L, Chang DZ, Beinart G, Wolff RA, Evans DB, Hassan MM, Abbruzzese JL. Effects of Base Excision Repair Gene Polymorphisms on Pancreatic Cancer Survival. Int J Cancer 120(8):1748-54, 2007. PMID: 17230526.
173. Li D, Day RS, Bondy ML, Sinha R, Nguyen NT, Evans DB, Abbruzzese JL, Hassan MM. Dietary mutagen exposure and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 16(4):655-61, 2007. PMID: 17416754.
174. Jiao L, Bondy ML, Hassan MM, Chang DZ, Abbruzzese JL, Evans DB, Smolensky MH, Li D. Glutathione S-transferase gene polymorphisms and risk and survival of pancreatic cancer. Cancer 109(5):840-8, 2007. PMID: 17265526.
175. Jiao L, Chang P, Pervez PF, Lai D, Abbruzzese JL, Li D. Polymorphisms of phase II xenobiotic-metabolizing and DNA repair genes and in vitro N-ethyl-N-nitrosourea-induced O6-ethylguanine levels in human lymphocytes. Mutat Res 627(2):146-57, 2007. e-Pub 2006. PMID: 17158087.
176. Jiao L, Zhu J, Hassan MM, Evans DB, Abbruzzese JL, Li D. K-ras mutation and p16 and preproenkephalin promoter hypermethylation in plasma DNA of pancreatic cancer patients: in relation to cigarette smoking. Pancreas 34(1):55-62, 2007. PMID: 17198183.
177. Jiao L, Hassan MM, Bondy ML, Abbruzzese JL, Evans DB, Li D.. The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype and pancreatic cancer risk. Cancer Lett 245(1-2):61-8, 2007. e-Pub 2006. PMID: 16458430.
178. Paracchini V, Raimondi S, Gram IT, Kang D, Kocabas NA, Kristensen VN, Li D, Parl FF, Rylander-Rudqvist T, Soucek P, Zheng W, Wedren S, Taioli E. Meta- and pooled analyses of the cytochrome P-450 1B1 Val432Leu polymorphism and breast cancer: a HuGE-GSEC review. Am J Epidemiol 165(2):115-25, 2007. e-Pub 2006. PMID: 17053044.
179. Lu J, Wei Q, Bondy ML, Li D, Brewster A, Shete S, Yu TK, Sahin A, Meric-Bernstam F, Hunt KK, Singletary SE, Ross MI, Wang LE. Polymorphisms and haplotypes of the NBS1 gene are associated with risk of sporadic breast cancer in non-Hispanic white women <or=55 years. Carcinogenesis 27(11):2209-16, 2006. e-Pub 2006. PMID: 16714331.
180. Lu J, Wei Q, Bondy ML, Yu TK, Li D, Brewster A, Shete S, Sahin A, Meric-Bernstam F, Wang LE. Promoter polymorphism (-786t>C) in the endothelial nitric oxide synthase gene is associated with risk of sporadic breast cancer in non-Hispanic white women age younger than 55 years. Cancer 107(9):2245-53, 2006. PMID: 17063466.
181. Zhu J, Rashid A, Cleary K, Abbruzzese JL, Friess H, Takahashi S, Shirai T, Li D. Detection of 2-amino-1-methyl-6-phenylimidazo [4,5-b]-pyridine (PhIP)-DNA adducts in human pancreatic tissues. Biomarkers 11:319-28, 2006. PMID: 16908439.
182. Li D, Frazier M, Evans DB, Hess KR, Crane CH, Jiao L, Abbruzzese JL. Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer. J Clin Oncol 24(11):1720-8, 2006. e-Pub 2006. PMID: 16520463.
183. Person MD, Shen J, Traner A, Hensley SC, Lo HH, Abbruzzese JL, Li D. Protein fragment domains identified using 2D gel electrophoresis/MALDI-TOF. J Biomol Tech 17(2):145-56, 2006. PMID: 16741242.
184. Li D, Liu H, Jiao L, Chang DZ, Beinart G, Wolff RA, Evans DB, Hassan MM, Abbruzzese JL. Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival. Cancer Res 66(6):3323-30, 2006. PMID: 16540687.
185. Li D, Jiao L, Li Y, Doll MA, Hein DW, Bondy ML, Evans DB, Wolff RA, Lenzi R, Pisters PW, Abbruzzese JL, Hassan MM. Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer. Carcinogenesis 27(1):103-11, 2006. e-Pub 2005. PMID: 15987714.
186. Jiao L, Bondy ML, Hassan MM, Wolff RA, Evans DB, Abbruzzese JL, Li D. Selected polymorphisms of DNA repair genes and risk of pancreatic cancer. Cancer Detect Prev 30(3):284-91, 2006. e-Pub 2006. PMID: 16844323.
187. Beger RD, Schnackenberg LK, Holland RD, Li D and Dragan Y. Metabolomic Models of Human Pancreatic Cancer Using 1D Proton NMR Spectra of Lipids in Plasma. Metabolomics 2:125-34, 2006.
188. Yokoi K, Shih LC, Kobayashi R, Koomen J, Hawke D, Li D, Hamilton SR, Abbruzzese JL, Coombes KR, Fidler IJ. Serum amyloid A as a tumor marker in sera of nude mice with orthotopic human pancreatic cancer and in plasma of patients with pancreatic cancer. Int J Oncol 27(5):1361-9, 2005. PMID: 16211233.
189. Li D, Ahmed M, Li Y, Jiao L, Chou TH, Wolff RA, Lenzi R, Evans DB, Bondy ML, Pisters PW, Abbruzzese JL, Hassan MM. 5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 14(6):1470-6, 2005. PMID: 15941958.
190. Zhu J, Abbruzzese JL, Izzo J, Hittelman WN, Li D. AURKA amplification, chromosome instability, and centrosome abnormality in human pancreatic carcinoma cells. Cancer Genet Cytogenet 159(1):10-7, 2005. PMID: 15860351.
191. Koomen JM, Li D, Xiao LC, Liu TC, Coombes KR, Abbruzzese J, Kobayashi R. Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery. J Proteome Res 4(3):972-81, 2005. PMID: 15952745.
192. Asano T, Yao Y, Zhu J, Li D, Abbruzzese JL, Reddy SA. The rapamycin analog CCI-779 is a potent inhibitor of pancreatic cancer cell proliferation. Biochem Biophys Res Commun 331(1):295-302, 2005. PMID: 15845392.
193. Koomen JM, Shih LN, Coombes KR, Li D, Xiao LC, Fidler IJ, Abbruzzese JL, Kobayashi R. Plasma protein profiling for diagnosis of pancreatic cancer reveals the presence of host response proteins. Clin Cancer Res 11(3):1110-8, 2005. PMID: 15709178.
194. Koomen JM, Zhao H, Li D, Nasser W, Hawke DH, Abbruzzese JL, Baggerly KA, Kobayashi R. Diagnostic protein discovery using liquid chromatography/mass spectrometry for proteolytic peptide targeting. Rapid Commun Mass Spectrom 19(12):1624-36, 2005. PMID: 15915451.
195. Touillaud MS, Pillow PC, Jakovljevic J, Bondy ML, Singletary SE, Li D, Chang S. Effect of dietary intake of phytoestrogens on estrogen receptor status in premenopausal women with breast cancer. Nutr Cancer 51(2):162-9, 2005. PMID: 15860438.
196. Ebrahimi B, Tucker SL, Li D, Abbruzzese JL, Kurzrock R. Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis. Cancer 101(12):2727-36, 2004. PMID: 15526319.
197. Shen J, Person MD, Zhu J, Abbruzzese JL, Li D. Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res 64(24):9018-26, 2004. PMID: 15604267.
198. Asano T, Yao Y, Zhu J, Li D, Abbruzzese JL, Reddy SA. The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells. Oncogene 23(53):8571-80, 2004. PMID: 15467756.
199. Soliman AS, Vulimiri SV, Kleiner HE, Shen J, Eissa S, Morad M, Taha H, Lukmanji F, Li D, Johnston DA, Lo H, Lau S, Digiovanni J, Bondy ML. High levels of oxidative DNA damage in lymphocyte DNA of premenopausal breast cancer patients from Egypt. Int J Environ Health Res 14(2):121-134, 2004. PMID: 15203457.
200. Koomen JM, Zhao H, Li D, Abbruzzese J, Baggerly K, Kobayashi R. Diagnostic protein discovery using proteolytic peptide targeting and identification. Rapid Commun Mass Spectrom 18(21):2537-48, 2004. PMID: 15468157.
201. Zhu J, Chang P, Bondy ML, Sahin AA, Singletary SE, Takahashi S, Shirai T, Li D. Detection of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine-DNA adducts in normal breast tissues and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 12(9):830-7, 2003. PMID: 14504191.
202. Li D, Zhu J, Firozi PF, Abbruzzese JL, Evans DB, Cleary K, Friess H, Sen S. Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer. Clin Cancer Res 9(3):991-7, 2003. PMID: 12631597.
203. Habib SL, Phan ML, Patel SK, Li D, Monks TJ, Lau S. Reduced constitutive 8-oxoguanine-DNA glycosylase expression and impaired induction following oxidative DNA damage in the tuberin deficient Eker rat. Carcinogenesis 24(3):573-582, 2003. PMID: 12663520.
204. Silva EG, Mistry D, Li D, Kuerer HM, Atkinson EN, Lopez AN, Shannon R, Hortobagyi GN. Elevated luteinizing hormone in serum, breast cancer tissue, and normal breast tissue from breast cancer patients. Breast Cancer Res Treat 76(2):125-30, 2002. PMID: 12452449.
205. Hassan MM, Hwang LY, Hatten CJ, Swaim M, Li D, Abbruzzese JL, Beasley P, Patt YZ. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 36(5):1206-13, 2002. PMID: 12395331.
206. Li D, Walcott FL, Chang P, Zhang W, Zhu J, Petrulis E, Singletary SE, Sahin AA, Bondy ML. Genetic and environmental determinants on tissue response to in vitro carcinogen exposure and risk of breast cancer. Cancer Res 62(16):4566-70, 2002. PMID: 12183407.
207. Firozi PF, Bondy ML, Sahin AA, Chang P, Lukmanji F, Singletary ES, Hassan MM, Li D. Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer. Carcinogenesis 23(2):301-6, 2002. PMID: 11872636.
208. Li D, Wang M, Firozi PF, Chang P, Zhang W, Baer-Dubowska W, Moorthy B, Vulimiri SV, Goth-Goldstein R, Weyand EH, DiGiovanni J. Characterization of a major aromatic DNA adduct detected in human breast tissues. Environ Mol Mutagen 39(2-3):193-200, 2002. PMID: 11921189.
209. Li D, Firozi PF, Zhang W, Shen J, DiGiovanni J, Lau S, Evans D, Friess H, Hassan M, Abbruzzese JL. DNA adducts, genetic polymorphisms, and K-ras mutation in human pancreatic cancer. Mutat Res 513(1-2):37-48, 2002. PMID: 11719088.
210. Xiong P, Bondy ML, Li D, Shen H, Wang LE, Singletary SE, Spitz MR, Wei Q. Sensitivity to benzo(a)pyrene diol-epoxide associated with risk of breast cancer in young women and modulation by glutathione S-transferase polymorphisms: a case-control study. Cancer Res 61(23):8465-9, 2001. PMID: 11731429.
211. Li D, Zhang W, Zhu J, Chang P, Sahin A, Singletary E, Bondy M, Hazra T, Mitra S, Lau SS, Shen J, DiGiovanni J. Oxidative DNA damage and 8-hydroxy-2-deoxyguanosine DNA glycosylase/apurinic lyase in human breast cancer. Mol Carcinog 31(4):214-23, 2001. PMID: 11536371.
212. Li D, Firozi PF, Chang P, Sahin A, Singletary E, Bondy M, Hazra T, Mitra S, Lau SS, Shen J, DiGiovanni J.. In vitro BPDE-induced DNA adducts in peripheral lymphocytes as a risk factor for squamous cell carcinoma of the head and neck. Int J Cancer 31:214-23, 2001. PMID: 11433411.
213. Li D, Firozi PF, Wang LE, Bosken CH, Spitz MR, Hong WK, Wei Q. Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis. Cancer Res 61(4):1445-50, 2001. PMID: 11245449.
214. Firozi PF, Vulimiri SV, Rajaniemi H, Hemminki K, Dragan Y, Pitot HC, DiGiovanni J, Zhu YH, Li D. Characterization of the major DNA adducts in the liver of rats chronically exposed to tamoxifen for 18 months. Chem Biol Interact 126(1):33-43, 2000. PMID: 10826652.
215. Randerath K, Randerath E, Zhou GD, Li D. Bulky endogenous DNA modifications (I-compounds) -possible structural origins and functional implications. Mutat Res 424(1-2):183-94, 1999. PMID: 10064860.
216. Li D, Wang M, Paul GP, Pitot HC, Dragan Y. Dietary oat lipids-induced novel DNA modifications and suppression of altered hepatic foci formation. Nutr Cancer 33(1):40-5, 1999. PMID: 10227042.
217. Li D, Zhang W, Sahin AA, Hittelman WN. DNA adducts in normal tissue adjacent to breast cancer: a review. Cancer Detect Prev 23(6):454-62, 1999. PMID: 10571655.
218. Wang M, Abbruzzese JL, Friess H, Hittelman WN, Evans DB, Abbruzzese MC, Chiao P, Li D. DNA adducts in human pancreatic tissues and their potential role in carcinogenesis. Cancer Res 58(1):38-41, 1998. PMID: 9426054.
219. Yu F-L, Wang M-Y, Li D, Bender W, Zheng WY. Evidence for the DNA binding and adduct formation of estrone and 17p-estradiol after dimethyldioxirane activation. Chem.-Bio. Inter 110:173-187, 1998.
220. Saito Y, Milross CG, Hittelman WN, Li D, Jibu T, Peters LJ, Milas L. Effect of radiation and paclitaxel on p53 expression in murine tumors sensitive or resistant to apoptosis induction. Int J Radiat Oncol Biol Phys 38(3):623-31, 1997. PMID: 9231689.
221. Li D, Dragan Y, Jordan VC, Wang M, Pitot HC. Effects of chronic administration of tamoxifen and toremifene on DNA adducts in rat liver, kidney, and uterus. Cancer Res 57(8):1438-41, 1997. PMID: 9108442.
222. Wang M, Dhingra K, Hittelman WN, Liehr JG, de Andrade M, Li D. Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues. Cancer Epidemiol Biomarkers Prev 5(9):705-10, 1996. PMID: 8877062.
223. Li D, Wang M, Cheng L, Spitz MR, Hittelman WN, Wei Q. In vitro induction of benzo(a)pyrene diol epoxide-DNA adducts in peripheral lymphocytes as a susceptibility marker for human lung cancer. Cancer Res 56(16):3638-41, 1996. PMID: 8705998.
224. Nath RG, Randerath K, Li D, Chung FL. Endogenous production of DNA adducts. Regul Toxicol Pharmacol 23(1 Pt 1):22-8, 1996. PMID: 8628916.
225. Li D, Wang M, Dhingra K, Hittelman WN. Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology. Cancer Res 56(2):287-93, 1996. PMID: 8542582.
226. Li D, Wang M, Liehr JG, Randerath K. DNA adducts induced by lipids and lipid peroxidation products: Possible relationships to I-compounds. Mutat Res 344:117-26, 1995. PMID: 7491129.
227. Moorthy B, Chen S, Li D, Randerath K. 3-Methylcholanthrene-inducible liver cytochrome(s) P450 in female Sprague-Dawley rats: possible link between P450 turnover and formation of DNA adducts and I-compounds. Carcinogenesis 14(5):879-86, 1993. PMID: 8504481.
228. Li D, Chen S, Randerath E, Randerath K. Oat lipids-induced covalent DNA modifications (I-compounds) in female Sprague-Dawley rats, as determined by 32P-postlabeling. Chem Biol Interact 84(3):229-42, 1992. PMID: 1423742.
229. Randerath K, Li D, Nath R, Randerath E. Exogenous and endogenous DNA modifications as monitored by 32P-postlabeling: Relationships to cancer and aging. Exptl Geront 27:533-49, 1992. PMID: 1426086.
230. Li D, Moorthy B, Chen S, Randerath K. Effects of cytochrome P450 inducers on I-compounds in rat liver and kidney DNA. Carcinogenesis 13(7):1191-8, 1992. PMID: 1638686.
231. Li D, Randerath K. Modulation of DNA modification (I-compound) levels in rat liver and kidney by dietary carbohydrate, protein, fat, vitamin, and mineral content. Mutat Res 275(1):47-56, 1992. PMID: 1372687.
232. Li D, Chen S, Randerath K. Natural dietary ingredients (oats and alfalfa) induce covalent DNA modifications (I-compounds) in rat liver and kidney. Nutr Cancer 17(3):205-16, 1992. PMID: 1437640.
233. Li D, Chen S, Becker FF, Randerath K. Specific reduction of I-compound levels in DNA from spontaneous hepatomas of 22-24 month old male C3H mice. Carcinogenesis 12(12):2389-91, 1991. PMID: 1747944.
234. Li D, Wang YM, Nath RG, Mistry S and Randerath K.. Effects of dietary vitamin E on I-compounds (putative indigenous DNA modifications) of rat liver and kidney. J Nutr 121:65-71, 1991.
235. Li DH, Wang YM, Nath RG, Mistry S, Randerath K. Modulation by dietary vitamin E of I-compounds (putative indigenous DNA modifications) in rat liver and kidney. J Nutr 121(1):65-71, 1991. PMID: 1992059.
236. Li DH, Xu DC, Chandar N, Lombardi B, Randerath K. Persistent reduction of I-compound levels in liver DNA from male Fischer rats fed choline-devoid diet and in resulting neoplasms. Cancer Res 50(23):7577-80, 1990. PMID: 2253208.
237. Li DH, Xu DC, Randerath K. Species and tissue specificities of I-compounds as contrasted with carcinogen adducts in liver, kidney and skin DNA of Sprague-Dawley rats, ICR mice and Syrian hamsters. Carcinogenesis 11(12):2227-32, 1990. PMID: 2124953.
238. Li DH, Randerath K. Association between diet and age-related DNA modifications (I-compounds) in rat liver and kidney. Cancer Res 50(13):3991-6, 1990. PMID: 2354447.
239. Randerath K, Li DH, Randerath E. Age-related DNA modifications (I-compounds): modulation by physiological and pathological processes. Mutat Res 238(3):245-53, 1990. PMID: 2188122.
240. Li DH, Randerath K. Strain differences of I-compounds in relation to organ sites of spontaneous tumorigenesis and non-neoplastic renal disease in mice. Carcinogenesis 11(2):251-5, 1990. PMID: 2302752.
241. Nath RG, Li DH, Randerath K. Acute and long-term effects of carbon tetrachloride on DNA modifications (I-compounds) in male mouse liver. Chem Biol Interact 76(3):343-57, 1990. PMID: 2225235.
242. Wang YM, Purewal M, Nixon B, Li DH, Soltysiak-Pawluczuk D. Vitamin E and cancer prevention in an animal model. Ann N Y Acad Sci 570:383-90, 1990. PMID: 2629607.
243. Li D, Chandar N, Lombardi B, Randerath K. Reduced accumulation of I-compounds in liver DNA of rats fed a choline-devoid diet. Carcinogenesis 10:605-7, 1989. PMID: 2924404.
244. Randerath K, Lu LJ, Li D. A comparison between different types of covalent DNA modifications (I-compounds, persistent carcinogen adducts and 5-methylcytosine) in regenerating rat liver. Carcinogenesis 9:1843-8, 1988. PMID: 3168163.
245. Li D, Novak R, Hsi B, Brockway B. Effects of timed single low-dose ethanol ingestion on the circadian rhythm of body temperature of rats monitored by the Data Sciences Dataquest III-Cardiotel System. Ann. Rev. Chronopharmacol 3:257-260, 1986.
246. Miller TA, Li D, Kuo YJ, Schmidt KL, Shanbour LL. Nonprotein sulfhydryl compounds in canine gastric mucosa: effects of PGE2 and ethanol. Am J Physiol 248:G137-44, 1985. PMID: 4014462.

Invited Articles

1. Li D, Abbruzzese JL. New strategies in pancreatic cancer: emerging epidemiologic and therapeutic concepts. Clin Cancer Res 16(17):4313-8, 2010. e-Pub 2010. PMID: 20647474.
2. Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic Cancer. Lancet 363(9414):1049-57, 2004. PMID: 15051286.
3. Li D, Jiao L. Molecular epidemiology of pancreatic cancer. Int J Gastrointest Cancer 33(1):3-14, 2003. PMID: 12909734.
4. Li D. Molecular epidemiology of pancreatic cancer. Cancer J 7(4):259-65, 2001. PMID: 11561602.

Other Articles

1. Mao Y, Tao M, Jia X, Li D Letter to editor, 'Diabetes was associated with a short survival of pancreatic cancer'. J Clin Oncol 33(18):2120-1, 2015. PMID: 25940720.
2. Bosetti C, Petersen GM, Li D, et al Reply to the letter to the editor 'The link between type 2 diabetes and pancreatic adenocarcinoma is yet to be established', by Rahman and Meeran. Ann Onc 25(11):2290-2291, 2014.
3. Bertuccio P, La Vecchia C, Silverman DT, Petersen GM, Bracci PM, Negri E, Li D, Risch HA, Olson SH, et al Reply to are cohort data on smokeless tobacco use and pancreatic cancer confounded by alcohol use?. Ann Onc 22:1931-1932, 2011.
4. Li D, Hassan MM, Abbruzzese JL Obesity and Survival Among Patients with Pancreatic Cancer-Reply. JAMA 302:1752-53, 2009.
5. Hassan MM, Li D, Abbruzzese JL In reply. J Clin Oncol 27:648-649, 2009.
6. Li D and Hassan MM Letter of response to comments on the article entitled "Passive Smoking and Use of Noncigarette Tobacco Products and Risk for Pancreatic Cancer. Cancer 112(3):672, 2008.
7. Asano T, Yao Y, Zhu J, Li D, Abbruzzese JL, Reddy SA Erratum: The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-κB and c-Myc in pacreatic cancer cells. Oncogene 24:4320, 2005.

Abstracts

1. Hatia RI, Javle M, Shroff RT, Chang P, Karatas E, Uruba S, Jalal PK, Hashim M, Li Donghui, Hassan MM. Estrogen replacement reduces risk of intrahepatic cholangiocarcinoma in American women. AASLD, 2022.
2. Grace Hamadeh, Aishwarya Lanka, Akram Shalaby, Rikita Hatia, Ahmed Shalaby, Adam Khalifa, Li Donghui, Milind Javle, Manal Hassan. Multi-factorial Etiology of Gallbladder Cancer: A USA Case-Control Population Study. AASLD, 2022.
3. Chen Yuan, Jihye Kim, Qiao-Li Wang, Alice A. Lee, Ana Babic, PanScan I-III Consortium; Laufey T. Amundadottir, Alison P. Klein, Li Donghui Marjorie L. McCullough, Gloria M. Petersen, Harvey A. Risch, Rachael Z. Stolzenberg-Solomon, Kimmie Ng, Edward L. Giovannucci, Meir J. Stampfer, Peter Kraft, Brian M. Wolpin. The age-dependent association of risk factors with pancreatic cancer. AACR, 2022.
4. Scheet P, Yu Y, Chang K, Hildebrandt M, Permuth J, <b>Li Donghui. Whole exome sequencing case-control study implicates truncating variants in ATM as major risk factors in pancreatic cancer. AACR, 2020.
5. Han, Y., Zhu, C., Byun, J., |BLi, Donghui., Hassan, M., Amos, C. LD score regression analysis of liver cancer using multi-traits from UK Biobank Genetic Epidemiology 44:487-488, 2020.
6. Zhong J, Jermusyk A, Wu L, Hoskins JW, Collins I, Zhang M Li Donghui, Yu K, Shu X-O, Chanock SJ, Wolpin BM, Stolzenberg-Solomon R, Olson S, Chatterjee N, Klein AP, Smith JP, Kraft P, Shi J, Petersen GM, Zheng W, Amundadottir LT. A Transcriptome-Wide Association Study (TWAS) Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer. AACR 79(13). e-Pub 2019.
7. N Walsh, H Zhang, P Hyland, Q Yang, E Mocci, M Zhang, EJ Childs, Z Wang, S Chanock, P Hartge, R Hoover, P Kraft, <Li D, EJ Jacobs, GM Petersen, BM Wolpin, HA Risch, LT Amundadottir, K Yu, AP Klein, RZ Stolzenberg-Solomon and members of the Pancreatic Cancer Cohort Consortium (PanScan) and Pancreatic Cancer Case Control Consortium (PanC4). Large pathway and gene set analysis of GWAS data identifies novel associations for pancreatic cancer. AACR, 2018. e-Pub 2018.
8. Du R, Sun J, Bi Y, Xu Y, Xu M, Chen Y, Wang W, Li D, Lu J. Thiazolidinedione therapy and the risk of breast cancer risk among diabetic women: results from a meta-analysis. Diabetes/Metabolism Research and Reviews. e-Pub 2017. PMID: 29125710.
9. Jia G, Royse K, Tang H, Li D, Chen L, Tinker L, Petersen G, Klein A, Richardson P, White DL, Sangi-Haghpeykar H, El-Serag HB, Jiao L. Genetic variations in the AGEs/AGER pathway and risk of pancreatic cancer. AACR, 2017.
10. Tang H, Jiang L, Stolzenberg-Solomon RS, Amundadottir LT, Risch HA,Klein AP, Wolpin BM, Petersen G, Chatterjee N, Li D, Kraft P, Wei P, on behalf of Pancreatic Cancer Cohort Consortium (PanScan) and Pancreatic Cancer Case Control Consortium (PanC4). Genome-wide gene-diabetes and gene-obesity interaction scan in 8255 cases and 11900 controls from Pancreatic Cancer Cohort Consortium and Pancreatic Cancer Case Control Consortium. AACR, 2017.
11. Shalaby A, Botrus G, Kaseb AO, Li D, Abdel-Wahab R, Wolff R, Lacin S, Javle M, Hawk E, Hassan M. The protective effect of physical activity on risk of hepatocellular carcinoma in USA. ASCO, 2016.
12. H Tang, P Wei, P Chang, Y Li, C Liu, D Li. Genome-wide scan for genetic markers modifying survival of pancreatic cancer patients. AACR, 2016.
13. D Yan, P Chang, D Li. Plasma HGF level is associated with obesity, increased risk and reduced survival of pancreatic cancer. AACR, 2016.
14. Shroff RT, Sathyanarayanan S, Zhang T, Naumov GN, Kar SP, Li D, Javle MM. Comprehensive analysis of potential predictive biomarkers for insulin-like growth factor type I receptor (IGF-1R) targeted therapy in pancreatic cancer. GI ASCO, 2011.
15. Fogelman DR, Wang XS, Hassan M, Li D, Javle MM, Varadhachary GR, Shroff RT, Overman MJ, Wolff RA, Abbruzzese JL. Serum cytokines may outweigh clinical factors in predicting weight loss in advanced pancreatic cancer. GI ASCO, 2011.
16. Li D, Moughan J, Chang P, Hoffman JP, Regine WF, Abrams RA, Safran H, Freedman GM, Guha C, Abbruzzese JL. RecQ1 A159C Polymorphism is associated with overall survival of patients with resected pancreatic cancer: a replication study in RTOG 9704. GI ASCO, 2011.
17. Dong X, Tang H, Hess KR, Abbruzzese JL, Li D. Glucose metabolism, gene polymorphisms, and clinical outcomes in pancreatic cancer. ASCO, 2010.
18. Huang TCJ, Li D, Weatherly J, Tang H, Gout PW, Wolff RA, Abbruzzese JL, Javle MM. Genetic polymorphisms of teh xc-cystine transporter (xCT) gene correlate with prognosis of patients with advanced pancreatic cancer. ASCO, 2010.
19. Shama MA, Tanaka M, Curley SA, Abbruzzese JL, Li D. Diabetes is associated with perineural invasion in pancreatic cancer and overall survival in surgically resected patients. ASCO, 2010.
20. Tanaka M, Bedrosian I, Chang GJ, You YN, Li D, Rodriguez-Bigas MA, Skibber JM, Abbruzzese JL, Eng C. Single nucleotide polymorphisms (SNP's) of hypoxia-related genes correlate with pathologic complete response (pCR) following neoadjuvant chemoradiation (chemoXRT) for locally advanced rectal cancer. ASCO, 2010.
21. Hassan HM, Kaseb AO, Shama MA, Vauthey JN, Lozano RD, Curley SA, Li D, Hassan M. Association between prior history of cholecystectomy and hepatocellular carcinoma (HCC) development: A case-control study in USA. ASCO, 2010.
22. Shroff RT, Javle MM, Dong X, Kumar SV, Krishnan S, Wolff RA, Abbruzzese JL, Li D.. Prognostic Value of Polymorphisms in the Insulin-Like Growth Factor Receptor (IGFR) Pathway in Patients with Locally Advanced Pancreatic Cancer (LAPC). JCO, 2009.
23. Li D, Dong X, Jiao L, Li Y, Evans DB, Wang H, Hess KR, Abbruzzese JL.. Effects of DNA Mismatch Repair Gene Polymorphisms on Clinical Outcome of Pancreatic Cancer. GI ASCO, 2009.
24. Li D, Morris J, Liu J, Hassan MM, Day RS, Bondy ML, Evans DB, Abbruzzese JL.. Association of Body Mass Index with Risk, Age of Onset and Survival of Pancreatic Cancer. Proc. Am. Assoc. Cancer Res 49, 2009.
25. Li D, Suzuki H, Dong X, Okazaki T, Hassan MM, Abbruzzese JL, Li D. Insulin-like growth factor gene polymorphisms and risk of pancreatic cancer. Proc. Am. Assoc. Cancer Res, 2008.
26. Dong X, Li Y, Jiao L, Evans DB, Abbruzzese JL, Li D. Significant Effects of Mismatch Repair Gene Polymorphisms on Pancreatic Cancer Survival. Proc. Am. Assoc. Cancer Res 48, 2008.
27. Javle MM, Okazaki T, Evans DB, Crane C, Abbruzzese JL, Li D. Polymorphisms of Genes Involved in Gemcitabine Metabolism Correlate with Prognosis in Patients Receiving Neoadjuvant Therapy for Pancreatic Cancer. J Clin Oncol 26, 2008.
28. Li D, Okazaki T, Suzuki H, Javle M, Jiao L, Evans DB, Abbruzzese JL. Genetic Variations in Drug Metabolism and DNA Damage Response and Repair as Predictors for Clinical Outcomes of Pancreatic Adenocarcinoma. 15th SPORE Investigator's Workshop, 2007.
29. Li D, Hassan MM, Khan R, Bondy ML, Abbruzzese JL, and Day RS.. Dietary Micronutrient Intakes and Risk of Pancreatic Cancer. Proc. Am. Assoc. Cancer Res 47, 2007.
30. Okazaki T, Jiao L, Evans DB, Abbruzzese JL, Li D.. Single nucleotide polymorphism of ATM and CHEK-1 genes are associated with survival of pancreatic cancer. Proc. Am. Assoc. Cancer Res 47, 2007.
31. Hassan MM, Okazaki T, Jiao L, Steven C, Thomas M, Brown T, Vauthey N, Abdalla E, Patt YZ, Abbruzzese JL, Li D.. Polymorphisms of manganese superoxide dismutase gene and susceptibility to hepatocellular carcinoma. Proc. Am. Assoc. Cancer Res 47, 2007.
32. Nooka AK, Chang DZ, Abbruzzese JL, Evans DB, Wolff RA, Hassan MM, Li D. Impact of NAT1 Polymorphism on Survival of Pancreatic Cancer. GI ASCO, 2007.
33. Li D, Okazaki T, Suzuki H, Javle M, Jiao L, Evans D, Abbruzzese JL. Genetic Variations in Drug Metabolism and DNA Repair as Predictors for Clinical Outcomes of Pancreatic Adenocarcinoma. Keyston Symposium: GI Cancer, 2007.
34. Eng-Wong J, Chang S, Husting S, Perkins SN, Nunuz N, Bondy ML, Li D, Singletary SE.. Premenopausal breast cancer and the association between estrogen receptor status, insulin-like growth factor-I (IGF-I), insulin-like growth factor binding protein-3 (IGFBP-3) and leptin. ASCO, 2006.
35. Busaidy NL, Yazbeck CF, Shah P, Evans DB, Li D, Geraci JM, Weiser MA. Resectable pancreatic cancer patients with diabetes have shorter survival than nondiabetics. ASCO, 2006.
36. Lin E, Li Y, Trent J, Burgess M, Patel R, Benjamin R, Li D, Chen L. Real Time Quantitative RT-PCR of CD133 mRNA: A Potential Angiogenic Surrogate Marker of Response for Patient With Metastatic Sarcoma. ASCO, 2006.
37. Jiao L, Hassan MM, Chang DZ, Abbruzzese JL, Li D.. Association of GSTP1, GSTM1, and GSTT1 Polymorphisms with Risk and Overall Survival of Pancreatic Cancer. Proc. Am. Assoc. Cancer Res 46, 2006.
38. Li D, Evans DB, Hess K, Frazier M, Crane C, Abbruzzese JL. Polymorphisms of RecQ1, RAD54L, ATM and XRCC1 Genes and Prognosis of Pancreatic Cancer. Proc. Am. Assoc. Cancer Res 46, 2006.
39. Li Y, Zhu JJ, Abbruzzese JL, Li D. RNA Mediated TM2 (beta) Gene Silencing Alters Neoplastic Phenotypes of Human Pancreatic Cancer Cell Lines. Proc. Am. Assoc. Cancer Res 46, 2006.
40. Hassan MM, Khan R, Mestry K, Bondy ML, Abbruzzese JL, Evans DB, Wolff RA, Chou TH, Ho L, Xiong HQ, Lenzi R, Vauthey N, Pisters PW and Li D.. Risk Factors of Pancreatic Cancer in The United States: Case-Control Study. Proc. Am. Assoc. Cancer Res 46, 2006.
41. Lu J, Wei Q, Bondy ML, Li D, Brewster A, Yu TK, Sahin A, Meric-Bernstam F, Hung KK, Singletary SE, Ross MI, Wang LE.. Polymorphisms and haplotypes of the NBS1 gene associated with risk of sporadic breast cancer in young women: A case-control study. Proc. Am. Assoc. Cancer Res 46, 2006.
42. Li D, Liu H, Evans DB, Abbruzzese JL, Chen J and Frazier M.. Genetic Polymorphisms as Significant Predictive Factors for Patients with Pancreatic Adenocarcinoma. The 13th SPORE Investigator Workshop, 2005.
43. Zhu J, Shen J, Person M, Abbruzzese JL, Li D. Protein expression profiles in pancreatic adenocarcinoma cell lines and pancreatic adenocarcinomas tissues detected by Western blot and immunohistochemistry. Proc Am Assoc Cancer Res 45:A3104, 2005.
44. Jiao L, Hassan MM, Evans DB, Abbruzzese JL, Li D. Genotype and Hyplotype of XRCC2, XRCC3 and Rad54L Genes and Risk of Pancreatic Cancer. Proc Am Assoc Cancer Res 45:A4090, 2005.
45. Hassan MM, Li Y, Mestry K, Imam M. Bondy ML, Abbruzzese JL, Evans DB, Wolff RA, Chou TH, Ho L, Xiong HQ, Lenzi R, Pisters PW, Li D. Genetic variations in MnSOD and CAT genes and the risk of pancreatic cancer. Proc Am Assoc Cancer Res 45:A4921, 2005.
46. Li D, Hassan MM, Jiao L, Frazier M, Evans DB, Abbruzzese JL. DNA Repair Gene Polymorphisms and Risk of Pancreatic Cancer. Proc Am Assoc Cancer Res 45, 2005.
47. Chang P, Hassan M, Abbruzzese JL, Evans DB, Wolff R, Lenzi R, Pisters PW, Nooka A, Li D. Background and H2O2-induced micronuclei in peripheral blood lymphocytes as a risk factor for pancreatic cancer. Proc. Am. Assoc. Cancer Res 45:A485, 2004.
48. Li D, Stuff J, Bondy M, Day S, Abbruzzese JL, Evans DB, Wolff R, Chou TH, Lenzi R, Pisters PW, Nooka A, Hassan M. Dietary exposure to heterocyclic aromatic amines and risk of pancreatic cancer. Proc. Am. Assoc. Cancer Res 45:A484, 2004.
49. Li Y, Ahmed M, Hassan M, Abbruzzese JL, Nooka A, Wolff R, Lenzi R, Evans DB, Pisters PW, Li D. Folate level, Methylenetetrahydrofolate Reductase Polymorphisms, and Risk of Pancreatic Cancer. Proc. Am. Assoc. Cancer Res 45:A486, 2004.
50. Jiao L, Hassan M, Abbruzzese JL, Evans DB, Wolff RA, Lenzi R, Chou TH, Pisters PW, Nooka A, Li D. Genetic and epigenetic changes in plasma DNA of pancreatic cancer patients - association with tobacco smoking and implication for early diagnosis. Proc. Am. Assoc. Cancer Res 45:A893, 2004.
51. Hassan M, Nooka A, Zhang W, Ahmed M, Thomas M, Brown T, Curley SA, Ellis ML, Vauthey N, Patt YZ, Li D. Polymorphisms of transforming growth factor-b1 (TFGFb1) gene and susceptibility to hepatocellular carcinoma. Proc. Am. Assoc. Cancer Res 45:A269, 2004.
52. Shen H, Person MD, Zhu J, Abbruzzese JL, Li D. Protein expression profiles in normal pancreatic tissues, pancreatitis, and pancreatic adenocarcinomas as detected by proteomics. Proc. Am. Assoc. Cancer Res 45:A3539, 2004.
53. Zhu JJ, Evans DB, Abbruzzese JL, Cleary K, Li D.. Detection of 2-Amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine-DNA Adducts in Pancreas Tissues and the Risk of Pancreatic Cancer. Proc. Am. Assoc. Cancer Res 45:A1917, 2004.
54. Zhu J, Abbruzzese JL, Izzo J, Hittelman WN, Li D. Aurora2 amplification and chromosome instability in human pancreatic cancer cell lines. Proc. Am. Assoc. Cancer Res 44:A1200, 2003.
55. Hassan M, Zhang WQ, Nooka A, Patt YZ, Ahmed M, Thomas M, Brown T, Curley SA, Vauthey JN, Ellis LM, Li D. C262T polymorphism of the catalase gene and susceptibility to hepatocellular carcinoma. Proc. Am. Assoc. Cancer Res 44:A2605, 2003.
56. Chang P, Hassan M, Abbruzzese JL, Evans DB, Wolff RA, Lenzi R, Pisters PW, Nooka A, Li D. In vitro carcinogen-induced DNA adducts as a risk factor for pancreatic cancer. Proc. Am. Assoc. Cancer Res 44:A4515, 2003.
57. Jiao L, Zhu J, Hassan M, Connor T, Issa JP, Abbruzzese JL, Wolff R, Lenzi R, Evans DB, Pisters PW, Li D. Is aberrant promoter hypermethylation of p16 and ppENK genes in pancreatic cancer related to environmental exposure? . Proc. Am. Assoc. Cancer Res 44:A2198, 2003.
58. Jiao L, Hassan M, Firozi PF, Abbruzzese JL, Evans DB, Wolff RA, Lenzi R, Pisters PW, Nooka A, Li D. Tobacco smoking, phase II drug metabolizing genes, and pancreatic cancer risk in Caucasians. Proc. Am. Assoc. Cancer Res 44:A2616, 2003.
59. Josyula S, Zhang W, Li D, Thompson PA. Apparent lack of random mutations in the replication control region of mitochondrial (mt) DNA in human breast tumors. Proc. Am. Assoc. Cancer Res 43:A212, 2002.
60. Zhu J, Chang P, Bondy ML, Sahin A, Singletary ES, Takahashi S, Shirai T, Li D. Detection of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP)-DNA adducts in normal breast tissues by immunohistochemistry and risk of breast cancer. Proc. Am. Assoc. Cancer Res 43:A5044, 2002.
61. Zhang W, Josyula S, Thompson PA, Li D. DNA mutations in the DLP6 control region of the mitochondrial (mt) genome in breast tissues from women with or without cancer. Proc. Am. Assoc. Cancer Res 43:A4080, 2002.
62. Xiong P, Bondy M, Li D, Shen H, Wang LE, Singletary E, Spitz MR, Wei Q. G2 sensitivity to gamma radiation and modification by the p53 codon 72 polymorphism in a Breast Cancer Case-Control Study. Proc. Am. Assoc. Cancer Res 43:A2850, 2002.
63. Hassan M, Zhang W, Zhu J, Patt YZ, Swaim M, Schwartz M, Ghalib R, Gudena V, Abbruzzese JL, Li D. Glutathione Peroxidase and GSH/GSSG in Hepatocellular Carcinoma and Cirrhosis in Relation to HCV and Alcohol. Proc. Am. Assoc. Cancer Res 43:A4299, 2002.
64. Bedeir AS, Soliman AS, El-Ghawalby N, Rashid A, E-Ghawalby A, Bassiouni N, Bondy M, Li D, Levin B, Abbruzzese JL, Hamilton SR. High Proportion of G-to-T Transversion in Codon 12 of the K-ras Proto-oncogene in Egyptian Pancreatic Cancer. Proc. Am. Assoc. Cancer Res 43:A1972, 2002.
65. Li D, Lukmanji F, Chang P, Zhang W, Zhu J, Petrulis E, Singletary SE, Sahin A, Bondy M. In vitro carcinogen-induced DNA adducts in breast tissues and lymphocytes as a susceptibility marker for breast cancer. Proc. Am. Assoc. Cancer Res 43:A5042, 2002.
66. Li D, Hassan M, Chang P, Zhu J, Schwartz M, Ghalib R, Gudena V, Abbruzzese JL, Patt YZ. Increased oxidative DNA damage in HCV and alcohol-related liver cirrhosis and hepatocellular carcinoma2002. Proc. Am. Assoc. Cancer Res 43:A2841, 2002.
67. Asano T, Yao Y, Zhu J, Li D, Abbruzzese JL, Reddy SA. The PI 3-kinase Pathway is Constitutively Activated in Pancreatic Cancer – Role of Tumor Suppressor MMAC/PTEN. Proc. Am. Assoc. Cancer Res 43:A1788, 2002.
68. Jiao L, Hassan M, Gudena V, Connor TH, Abbruzzese JL, Li D. Susceptibility to Pancreatic Cancer and Genetic Polymorphisms of Cytochrome P450 2E1 and O6-Alkylguanine DNA Alkyltransferase gene. Proc. Am. Assoc. Cancer Res 43:A2849, 2002.
69. Soliman AS, Bondy M, El-Ghawalby N, E-Ghawalby A, Bassiouni N, Li D, Bedeir AS, Hamilton SR, Levin B, Abbruzzese JL. Unusually high rate of young-onset pancreatic cancer in the East Nile Delta region of Egypt. Proc. Am. Assoc. Cancer Res 43:A2850, 2002.
70. Jiao L, Firozi PF, Connor T, Li D. Codon 143 Polymorphism of AGT Gene in Pancreatic Cancer. Proc. Am. Assoc. Cancer Res 42:A1844, 2001.
71. Li D, Firozi PF, Zhang W, Shen H, DiGiovanni J, Lau S, Evans H, Friess H, Hassan M, Abbruzzese JL. DNA Adducts, genetic polymorphisms and K-ras mutation in human pancreatic cancer. Proc. Am. Assoc. Cancer Res 42:A3567, 2001.
72. Chang P, Soliman AS, Li D. Levels of O6-methylguanine and O6-methylguanine methyl transferase in colorectal tumors. Proc. Am. Assoc. Cancer Res 42:A3207, 2001.
73. Firozi PF, Zhu J, Sen S, Kuang J, Abbruzzese JL, Evans BD, Li D. STK15 amplification and overexpression in human pancreatic cancer. Proc. Am. Assoc. Cancer Res 42:A2659, 2001.
74. Li D, Wang MY, Dhingra K, Hittelman WN. Aromatic DNA adducts in human breast tissues: Possible involvement of carcinogen exposure in breast cancer etiology. International Conference on Carcinogenesis and Risk Assessment: Etiology of Breast and Gynecological Cancer. Austin, TX, 2000.
75. Soliman AS, Li D, Bondy M. Oxidative dDNA damage and aromatic DNA adducts in patients with colorectal cancer in Egypt. Gastroenterology 118:5079 Part 2 Suppl, 2000.
76. Moorthy B, Chen S, Li D, Randerath K. 3-Methylcholanthrene-inducible liver cytochrome(s) P450 in rats: Possible link between P450 turnover and formation of DNA adducts and I-compounds. Proc. Am. Assoc. Can. Res 34, 2000.
77. Li D, Firozi PF, Chang P, Sahin A, Singletary E, DiGiovanni J, Bondy M. Carcinogen exposure and genetic susceptibility in breast cancer. Proc. Am. Assoc. Cancer Res 41:A2678, 2000.
78. Li D, Zhang W, Chang P, Thomale J, Rajewsky MF, Hittelman WN. DNA adduct measurement by dual fluorescence labeling, laser scanning cytometry and tyramide signal amplification. Proc. Am. Assoc. Cancer Res 41:A3596, 2000.
79. Firozi PF, Abbruzzese JL, Evans DB, Friess H, Li D. DNA adducts, oxidative DNA damage and genetic polymorphisms in pancreatic cancer. Proc. Am. Assoc. Cancer Res 41:A3725, 2000.
80. Xiong P, Li D, Wang LE, Shen H, Bondy M, Singletary E, Spitz MR, Wei Q. GSTM1 and XRCC1 Polymorphisms Modify Sensitivity to Bezo[a]pyrene Diol Epoxide in Breast Cancer Patients. Proc. Am. Assoc. Cancer Res 42:A3226, 2000.
81. Xiong P, Li D, Wang LE, Bondy ML, Singletary SE, Spitz MR, Wei Q. Increased BPDE-induced mutagen sensitivity in breast cancer. Proc. Am. Assoc. Cancer Res 41:A, 2000.
82. Soliman AS, Chang P, Bondy M, Levin B, Khaled HM, Li D. Oxidative DNA damage and aromatic DNA adducts in patients with colorectal cancer in Egypt. Proc. Am. Assoc. Cancer Res 41(A), 2000.
83. Zhang W, Chang P, Sahin A, Singletary SE, Bondy M, Hazra T, Mitra S, DiGiovanni J, Li D. Oxidative stress and repair of oxidative DNA damage in human breast tissues. Proc. Am. Assoc. Cancer Res 41:A1494, 2000.
84. Li D, Firozi PF, Wang LE, Spitz MR, Hong WK, Wei Q. Sensitivity to DNA damage induced by BPDE as a risk factor for human lung cancer. Proc. Am. Assoc. Cancer Res 41:A3799, 2000.
85. Zhu YH, Sahin A, Zhang WQ, Li D. Expression of COX-II in human breast tissues and mammary epithelial cell lines. Proc. Am. Assoc. Cancer Res 40:A2377, 1999.
86. Firozi PF, Du YQ, Li D. Genetic polymorphism, DNA adducts and breast cancer. Proc. Am. Assoc. Cancer Res 40:A3745, 1999.
87. Zhu YH, Hazra T, Li D. Oxidative DNA damage and expression of 8-OH-dG repair genes in human mammary epithelial cells. Proc. Am. Assoc. Cancer Res 40:A4621, 1999.
88. Li D, Zhang WQ, Wang MY, Zhu YH, Hittelman WN, Sahin A. Cellular distribution of aromatic DNA adducts in normal breast tissues of women with breast cancer. Proc. Am. Assoc. Can. Res 39(Ab):3342, 1998.
89. Wang M, Abbruzzese J, Evans DM, Abbruzzese M, Chiao P, Hittelman WN, Li D. Aromatic and lipid peroxidation-related DNA adducts in human pancreatic cancer. Proc. Am. Assoc. Cancer Res 38:A4217, 1997.
90. Li D, Dragan Y, Jordan VC, Wang M, Pitot HC. Effects of chronic tamoxifen and toremifene exposure on DNA adducts in rat liver, kidney and uterus. Proc. Am. Assoc. Can. Res 38:A871, 1997.
91. Wei Q, Cheng L, Li D, Wang M, Gu J, Jiang H, Hong WK, Spitz MR. Genetic damage induced by benzo[a]pyrene diol epoxide and risk of lung cancer. Proc. of 28th Environmental Mutagen Society Annual Meeting, 1997.
92. Wang MY, Liehr JG, Nath RG, Hittelman WN, Li D. A 4-hydroxynonenal-DNA adduct in target tissues: A potential etiological biomarker. Proc. Am. Assoc. Can. Res 37:A/512, 1996.
93. Li D, Wang MY, Moorthy B, Hittelman WN. A benzo[a]pyrene (BP)-related DNA adduct detected in normal breast tissues of women with breast cancer. Proc. Am. Assoc. Can. Res 37:A824, 1996.
94. Nath RG, Cohen L, Li D, Ocando JE, Chung FL. Detection of exocyclic 1,N2 -propanodeoxyguanosine adducts in mammary gland DNA of humans and rats. Proc. Am. Assoc. Can. Res 36:A828, 1995.
95. Wang MY, Liehr JG, Dhingra K, Hittelman WN, Li D. Detection of malondialdehyde-induced DNA adducts in human breast tissues by 32P-postlabeling assay. Proc. Am. Assoc. Can. Res 36:A827, 1995.
96. Li D, Wang MY, Dhingra K, Hittelman WN. Discovery of a 4-hydroxynonenal induced DNA adduct in human breast tissues by 32P-postlabeling assay. Proc. Am. Assoc. Can. Res 36:A826, 1995.
97. Li D, Wang MY, Dhingra K, Hittelman WN. Normal adjacent tissues of breast cancer patients contain aromatic DNA adducts. Proc. Am. Assoc. Can. Res 36(A666), 1995.
98. Hinrichsen L, Li D, Randerath K, Sudilovsky O. Liver I-compounds in PVG rats, resistant to promotion by a choline-devoid (CD) diet. Proc. Am. Assoc. Can. Res 35:A826, 1994.
99. Li D, Wang M-Y, Liehr JG, Randerath K. Covalent DNA modifications induced by methanol extractable lipids of oats in vitro. Proc. Am. Assoc. Can. Res 34:A815, 1993.
100. Li D, Chen S, Randerath E, Randerath K. Oat lipids induced covalent DNA modifications (I-compounds) in female Sprague-Dawley rats, as determined by 32P-postlabeling. Proc. Am. Assoc. Can. Res 33:A777, 1992.
101. Nath RG, Li D, Randerath K. Effects Of CCI4 on DNA modifications (I-compounds) in male mouse liver. Proc. Am. Assoc. Can. Res 32:A670, 1991.
102. Li D, Chen S, Moorthy B, Randerath K. Modulation of I-compounds by cytochrome P-450 inducers in rat liver DNA. Proc. Am. Assoc. Can. Res 32:A643, 1991.
103. Li D, Xu DC, Randerath K. Comparison of I-compound and carcinogen-adduct profiles in DNA of rats, mice, and hamsters. Proc. Am. Assoc. Cancer Res 31:A555, 1990.
104. Li D, Randerath K. Nutritional modulations of I-compounds (putative indigenous DNA modifications) in rat liver and kidney. Proc. Am. Assoc. Can. Res 30:A778, 1989.
105. Li D, Chandar N, Lombardi B, Randerath K. Loss of I-compounds in liver DNA of rats fed a choline-devoid diet. Proc. Am. Assoc. Can Res 29:A437, 1988.
106. Li D, Wang Y-M, Nath RG, Parekh S, Randerath K. Vitamin E effects on agedependent DNA modifications (I-compounds) in rat liver and kidney. Proc. Am. Assoc. Cancer Res 29:A581, 1988.

Book Chapters

1. Li Donghui. Risk Factors and Genetic Predisposition. In: In: Pancreatic Cancer: A multidisciplinary Approach. Springer Nature Switzerland AG, 2022.
2. Li D, Mao Y. Diabetes as a Risk Factor of Pancreatic Cancer. In: The Pancreapedia: Exocrine Pancreas Knowledge Base. DOI.10.3998/panc.2015.2, 2015.
3. Wolff RA, Crane CH, Li D, Maitra A. Neoplasms of the Exocrine Pancreas. In: Holland-Frei Cancer Medicine. BC Decker, Shelton, 2015.
4. Li D. Obesity and Pancreatic Cancer. In: Energy Balance and Cancer. Springer: New York, 2013.
5. Jiao L, Li D. Genetic Epidemiology of Pancreatic Cancer. In: Molecular Genetics of Pancreatic Cancer. Springer: New York, 2012.
6. Wolff RA, Crane CH,Li D, Abbruzzese JL, Evans DB. Neoplasms of the Exocrine Pancreas. In: Holland-Frei Cancer Medicine. 8. BC Decker, Shelton, 2010.
7. Jiao L, Li D. Epidemiology: World Overview, Risk Factors, and Prospects for Prevention. In: Pancreatic Cancer. Springer: New York, 2009.
8. Wolff RA, Crane CH, Li D, Abbruzzese JL, Evans DB. Neoplasma of the Exocrine Pancreas. In: Cancer Medicine. 7. BC Decker, Shelton, 1331-58, 2006.
9. Li D, Jiao L. Epidemiology. In: Pancreatic Cancer. Jones Bartlett Publishers, 103-12, 2005.
10. Li D. Epidemiology and Molecular Epidemiology of Pancreatic Cancer. In: Gastrointestinal Oncology. Oxford University Press, 329-335, 2004.
11. Li D. Molecular Epidemiology. In: Pancreatic Cancer. Springer-Verlag: New York, 1-12, 2001.
12. Dragan YP, Sargent L, Li D, Jordan VC, Pitot HC. The effects of triphenylethylene antiestrogen on parameters of multistage hepatocarcinogenesis in the rat. In: Hormonal Carcinogenesis. Lavoisier: France, 124-135, 2000.
13. Yang K, Fang J-L, Li D, Chung F-L, Hemminki K. 32P-postlabeling with high-performance liquid chromatography for analysis of abundant DNA adducts in human tissues. In: Exocyclic DNA Adducts in Mutagenesis and Carcinogenesis. IARC Publications, 205-18, 1999.
14. Li D, Randerath K, Randerath E. 32P-Postlabeling analysis of chemical DNA damage. In: Synthesis and Applications of Isotopically Labeled Compounds. John Wiley & Sons Ltd: New York, 21-31, 1998.
15. Randerath K, Li D, Moorthy B and Randerath E. I-compounds-endogenous DNA markers of nutritional status, aging tumor promotion and carcinogenesis. In: Postlabeling Methods for Detection of DNA Adducts. IARC Scientific Publications, 157-65, 1993.